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INTRODUCTION 
 
 Health is defined as a state of complete physical, mental and social well 
being and not merely the absence of disease or infirmity. To be healthy, body, 
mind and soul should function in harmony. An imbalance to this harmony 
creates disease to both body and mind. Diseases pose great challenge to the 
mankind, resulting in mortality and morbidity. 
 All ancient civilizations – Egyptian, Babylonian, Indian and Chinese 
developed their own system of medicine. Siddha is a traditional medicine of 
India which is believed to be originated from Lord Shiva and then reached 
from Sage Agasthiar to Siddhars. Siddhars are spiritual scientists who lived and 
maintained their bodies as they desired best. 
 ‘fhug;gh rpj;jd; fw;gj;Njh nlhd;wpf; 
  ifyhrg; ghrkjhaf; fUjp tho;thd; 
 Neug;gh fw;gkij Az;L Njwp 
  eprkhd thrpapw;nrd; wpUg;ghd; whNd”. 
 
According to Siddha system of medicine, there are three basic 
constituent complexes in the physiological system called doshas. They are 
Vatha, Pitha and Kapha. Between them, they sustain the whole body 
metabolism. Good health implies an iteal balance between the three doshic 
facters. Whenever the doshas, either Vatha, Pitha or Kapha gets deranged, 
disease occurs. If these doshas are rearranged, by applying the principle and 
practice of siddha medicine, recurrence of diseases  is prevented. 
 The Siddha system of medicine is not only curative but also preventive, 
and possess rehabilitation and rejenuvation aspects of its  own kind, than any 
other systems of Medicine in World.  That is the speciality of our Sirappu 
Maruthuvam Department.  Here specialization is given to preventive, curative 
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and rejenuvative procedures along with Varmam, Enbumurivu, Thokkanam, 
Thol noigal etc., 
SIRAPPU MARUTHUVAM 
 Sirappu Maruthuvam is a special branch of siddha medicine that deals 
with the study of  
1. Yoga and Kayakalpam 
2. Varman and Thokkanam 
3. Muppu 
4. Enbu murivu 
5. Kirigai. 
6. Thol Noigal 
Yoga and Kayakalpam: 
 Yoga means integration of the individual’s soul (Jeevatma) and the 
Supreme soul (Paramatma). The eight types of yoga are quoted in 
Thirumanthiram as follows. 
 ‘,ak epakNk vz;zpyh> Mjdk; 
  eaKW gpuhzh ahkk; gpuj;jpahfhuQ; 
   rakpF jhuiz jpahdQ; rkhjp 
  maKWk; ml;lhq;f khtJ khNk” 
-  jkpo; %thapuk; 
1. Iyama       5. Prathyakara 
2. Niyama   6. Dharana 
3. Asanas   7. Thiyana 
4. Pranayama   8. Samadhi. 
Yoga is the science of right living and works on all aspects of life; 
physical, vital, mental, emotional, psychic and spiritual. 
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According to Patanjali, yoga consists of eight limbs, which are all 
equally important and are related as parts of a whole.  They are as follows. 
1. Five universal commandments (Iyama) : aimed at creating a 
‘better’ world; not harming anyone or anything; truthfulness; non-
stealing; leading a Godly, chaste life and being non-grasping. 
2. Five personal disciplines (Niyama): cleanliness, self contentend, 
self-discipline, self study and study of the scriptures and dedication 
to God. 
3. Practice of postures (Asana): “Sthiram sukham aasanam” meaning 
that position which is comfortable and steady. Asanas are specific 
body postures which open the energy channels and psychic centres. 
4. Practice of breath control (Pranayama): practising breathing 
techniques with care and discrimination. 
5. Detachment from worldly activities (Pratyahara): Developing a 
non-attached attitude of body and mind. 
6. Concentration (Dharana): Being able to hold on to a subject 
mentally. 
7. Meditation (Dhyana): developing a quiet meditative state. 
8. Transconciousness a state of bliss (Samadhi) :Attaining 
   a state of absorption in a subject or in the Divine. 
 
Kaya Kalpha (Rejenuvating therapy or Panacea) 
 The Siddhars developed a discipline for all the human beings called 
Kaya Kalpa designed to cure all diseases and extend life expectancy of 
mankind..  The kaya kalpa drugs are said to prevent not only degenerated 
condition but also rejenuvate individual’s normal health. 
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‘fw;gj;ij Az;lhy; fhak; mopahJ  
 fw;gj;jpdhNy fhzyhk; ifiyia 
 fw;gj;jpdhNy fhzyhk; Nrhjpia 
 fw;gj;jpdhNy fhiyAq; fl;bNl” 
       - jpUke;jpuk; 
Muppu 
 ‘Kg;nghUisr; Rl;L KOjOJ ePwhf;fpj; 
 jg;ghk Yz;L epiy rhH” 
- fhrGRz;lH Fws; 
  ‘$WkkpHjj;ij Az;bAwg; ghHf;fpy; 
  $Wk; gpwg;gWf;f yhk; 
       -  xsit Fws; 
 
Muppu is an important aspect in Siddha system of medicine.  It 
promotes the efficacy of the drugs. It rejenuvates thehuman body. It converts 
elements of lower atomic weight to gold and silver. 
 
Thokkanam 
 Thokkanam a kind of treatment, applied to the patient with or without 
medicated oil applying only by trained massager.Thokkanam or physio therapy 
basically used in all vatha diseases and also in pitha and kapha diseases.  It 
eliminates the toxic wastes if accumulated in the body.  It nourishes and 
normalizes the muscles, blood and the skin in a normal physiological condition.   
Kirigai 
 Azhal humour plays a major role in psychiatric disorders. Mental 
disordered are explained in Agasthiar Kanagamani -100 and Yoogi 
Chinthamani-800. 
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Fracture 
 It is possible to treat anytype of bone fracture followed by injury or 
trauma or pathological changes.  By applying medicated oils like vasavennai 
the nerve can be activated in order to avoid the fracture complication like the 
atrophy or dysfunction of nerve if left untreated. 
Thol Noigal: 
 Diseases of skin are elaborately enumerated in various works of siddhars 
like Thirumoolar, Yoogi, Agasthiar etc. The remedies given by them have 
excellent clinical recovery. 
The author has done the research work on one type of vatha disease – 
“AZHAL KEEL VAYU” which is a major cause of morbidity in elderly 
throughout  world.Azhal keel vayu could be compared with Osteo arthritis 
which has no complete cure worldwide.So the author selected the topic for the 
dissertation.The author’s choice of drugs for the clinical study were  
1) Perarathai chooranam - Internally 
-  Reference Gunapadam Mooligai Vagauppu – Page 28 
      2) Nathaichoori Ennai – Externally 
   - Reference –Sarabhendrar Vaidhya Muraigal 
                  (Vaadha Rogha Chikitchai)- Page 1  
Research is discovery of truth. The author humbly contributes this 
research work to the glory of Holy Siddha system of medicine. 
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AIM AND OBJECTIVES 
 
 The disease “Azhal Keel Vayu” is a major ailment of the elderly.  
Though there is no mortality in this disease, its clinical condition worsens in 
elderly people. The purpose of author’s work is to elucidate a good medicine 
from ancient Siddha literatures and to create hope and faith in their treatment.  
Their being a preliminary endeavour by the author, as if it would be a helping 
hand to the sufferers.  With this view this dissertation subject was undertaken. 
 1. To prove the efficacy of our Siddha Medicine to the world. 
2. To study the clinical cause of the disease “Azhal Keel Vayu” 
with keen observation on the Aetiology, Pathology, Diagnosis, 
Prognosis, Complications and the Treatment by making use of 
Siddha aspect. 
3. To expose the unique diagnostic methods mentioned by Siddhars, 
to know the disease “Azhal Keel Vayu” alters the normal 
condition under the topic Mukkutram, Poripulangal, Ezhu Udal 
Kattukkal and Envagai thervugal. 
4. To know the extent of correlation of Aetiology, Classification, 
Signs and Symptoms of Azhal Keel Vayu in Siddha aspect with 
Osteo arthritis in Modern medicine. 
5. To have an idea about the incidence of the disease with age, sex, 
socio-economic status and climatic conditions. 
6. To have a detailed clinical investigations. 
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7. To have a clinical trial on Azhal Keel Vayu tha author has given 
the drugs, Perarathai Chooranam as internal medicine and 
Nathaichoori Thylam as external medicine. 
8. To evaluate the Bio-chemical and Pharmacological effects of trial 
medicine. 
9. To use modern parameters to confirm the diagnosis and prognosis 
of the disease. 
10. To pave way for further research work in future. 
 
 
 
 
 
8 
 
REVIEW OF SIDDHA LITERATURE 
 
               ‘cUnghUs; jhq;FKlYKapWk; 
clw;fhjhu nkhd; gQ;rG+jg; 
gQ;rPfuzg; ghz;ikahnkdTk; 
capHf;fhjhu KapHj;jh njdTk;> 
Kg;gphpthfp Kf;FzkZfp 
cliyAKapiuA Nkhk;gpf; fhj;J> 
tUnkdKJkiw tFf;Fe;JzpNg” 
     - Neha;ehly; I 
fU cilikiaj; jhq;FtJ clYk; capUkhFk;. capUf;F 
MjhukhtJ gQ;rG+jq;fspdhyhd capHj;jhJf;fshFk;. mit thjk;> 
gpj;jk;> fgk; MFk;. clYf;F MjhukhtJ gQ;rG+jq;fspdhyhd 
clw;whJf;fshFk;. Mit rhuk;> nre;ePH> nfhOg;G> vd;G> %is> kw;Wk; 
Rf;fpyk; my;yJ RNuhzpjk;. 
Neha; Vw;gl fhuzk;: 
 czT> nray; Mfpatw;wpd; khWghLfshy;> VO 
clw;whJf;fshyhd clypw;F tsp> moy;> Iak; vd;w %d;W 
capHj;jhJf;fs; kpFe;Njh> Fiwe;Njh> clw;whJf;fspd; njhopiy 
khWglr; nra;J> Njfj;jpd;fz; cz;lhf;Fk; Fzq;fspd; fhhpaNk 
‘Neha;” vdg;gLk;. 
Neha; fzpg;G: 
  ‘kjpj;jplw;fUik tha;e;j 
   khz;ghpfhunkDy;yhj 
  Jjpj;jpl TzHe;jh NdDe; 
   Jfswg; gzpapd;wd;ik 
  gjpj;jplTzuhdhfpw; 
   gaDwhdhfhyhNd 
  tpjpj;jpL gpzpj;jpwj;ij 
   tpsk;GJ Kjw;fz;kd;Ndh” 
     - rpfpr;rh uj;d jPgk; 
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 ghpfhu Kiwfs; ahTk; njhpe;jpUe;jhYk; Neha; ehly; Neha; 
Kjisnyd;Dk; gpzpapd; jd;ik ed;wha; fw;WzHjy; mtrpakhFk;. 
 Neha; fzpg;gpy; Kjd;ikaplk; tfpg;gJ vz;tifj; NjHthFk;. 
 ‘nka;f;Fwp epwe;njhdp tpopehtpUkyk; iff;Fwp”   
        - NjiuaH 
eh> epwk;> nkhop> tpop> kyk;> ePH> ehb kw;Wk; ];ghprk;. 
 
Nehapid fzpf;f kw;w KiwfshtJ: 
1. nghwpahy; mwpjy;: %f;F> eh> fz;> Njhy;> nrtp Mfpa 
Ik;nghwpfspd; %yk; Nehapid mwpjy;. 
2. Gydhy; mwpjy;: ehw;wk;> Rit> xsp> CW> Xir Mfpa 
Ik;nghwpfspd; %yk; Nehapid mwpjy;. 
3. tpdhjy;: Nfl;lwpjy; 
kUj;Jtk;: 
 gpzpf;fg;gl;l Kf;Fw;wq;fs;> VO jhJf;fis jj;jk; epiyf;F 
nfhz;L tUtNj kUj;Jtj;jpd; flikahFk;. 
kUj;Jtk; 3 tifg;gLk;:  1 Njt kUj;Jtk;>  
2. khDl kUj;Jtk; 
3. mRu kUj;Jtk; 
kUe;Jfs; 3 tifg;gLk;:  1. %ypif nghUl;fs; 
     2. capHg; nghUl;fs; 
     3. jhJf;fs; 
¾ ,itfis gf;Ftkhf jahhpj;J cl;nfhz;Lk; 
ntspg;gpuNahfkhf cgNahfpj;Jk; Neha;fisfg; Nghf;f 
Ntz;Lk;. 
¾ kUe;Jfis Neha; jPHf;f gad;gLj;Jk; NghJ mtw;wpd; Rit 
tPhpak;> tpghfk; mwptJ ,d;wpaikahjJjhFk;. 
¾ Ritfs; 6 tifg;gLk; mit ,dpg;G> Gspg;G> cg;G> ifg;G> fhHg;G 
kw;Wk; JtHg;G. 
¾ tPhpak; 2 tifg;gLk; mit ntg;gk; kw;Wk; jl;gk;. 
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 fPy; thA 
 
rpj;j kUj;Jtj;jpy; vz;gJ tif tsp Neha;fs; gw;wp 
$wg;gl;Ls;sJ.  moy; fPy; thA vd;gJ> fPy;thA vd;w jiyg;gpd; fPo; 
$wg;gl;l gj;J tiffSs; xd;W.  fPy;thA vd;gJ %l;Lfspy; Vw;gLk; 
Neha;fis Fwpg;gjhFk;. 
NtW ngah;fs;: 
re;Jtyp> %l;Ltyp> Nkf#iy> Klf;F thA> Mkthjk;> re;J 
thjk;> #iyfl;L> re;jpf rpNy\;k Nuhfk;> thj#iy> thANuhfk;. 
 ‘jhdhd fPy;thj Nuhfk; Ngiu 
  rhw;WfpNwd; ePawpa tpgukhf 
 khdhd tha;TNuhfk; thjNuhfk; 
  kfj;jhd Klf;FthA> Klf;Fthjk; 
 Njdhd re;jPf rpNyl;Lk Nuhfk; 
  njspthd iffhypy; gpbg;G Nuhfk; 
 Cdhd urthjk; #iyf;fl;L 
  Cj;jkNd re;jpthjk; thjFiyahNk  (537) 
 Mnkd;w ,j;jidAk; mjw;Fg; Nguhk;. 
      - mfj;jpaH Fzthflk; 
fhuz ngah;fs;: 
Neha; fhuzk;    -   Nkf #iy 
Kf;Fw;w epiy khWghL    -   thj #iy 
          re;jpf rpNy\;k Nuhfk; 
          re;J thjk; 
,lj;ij nfhz;L    -    %l;L typ 
       re;J typ 
       Mk thjk; 
FwpFzq;fis nfhz;L   -    #iyfl;L 
           Klf;Fthjk; 
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Neha; ,ay;: 
fPy;thA vd;Dk; tsp NehahdJ typ> tPf;fk;> Fj;jy;> %l;Lfis 
mirf;f rpukk;> tpiwg;Gj;jd;ik> Ruk;> grpapd;ik> Nrhif Mfpa 
FwpFzq;fis cilajhFk;. 
‘tspAaike; jd;dpiy nfl;L 
 typAld; tPf;fr; RuKk; fha;e;J 
 %l;Lfs; NjhWk; KLf;fpNa nehe;J 
 %l;Lfs; jd;dpy; ePUk; Rue;J 
 jhq;nfhzh typAkh nehe;jpLkk;Nk” 
- rghgjp ifNaL 
thjKk;> fgKk; jd;dpiyf; nfLtjhy; %l;Lfspy; typ tPf;fk;> 
ePh;Nfhh;j;jy; Mfpait gpwf;fpd;wd. 
 
Neha; tiffs;: 
1. tsp fPy; thA 
2. moy; fPy; thA 
3. Ia fPy; thA 
4. tsp moy; fPy; thA 
5. moy; tsp; fPy; thA 
6. tsp Ia fPy; thA 
7. moy; Ia fPy; thA 
8. Ia tsp fPy; thA 
9. Ia moy; fPy; thA 
10. Kf;Fw;w fPy; thA 
Neha; tUk; top 
czT> gof;ftof;fq;fs;> MkNjhlk;> Rw;Wg;Gw #o;epiy 
Mfpait Kf;Fw;wj;jpy; khWghL Vw;gLj;jp Nehia cz;lhf;FfpwJ. 
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Rw;Wg;Gw #o;epiy: 
        ‘thj th;j;jid fhyNkNjh ntd;dpy; 
  kUTfpd;w Mdp fw;fl khFk; 
  Mjitg; grpNahL fhh;j;jpif jd;dpy; 
  mlUNk kw;w khjq;fs; jd;dpy; 
  NghfNs rkpf;Ffpd;w fhykhFk;” 
  nghUe;jpNa aptH njhopy; jhd; fz;bwj;jy; 
  fhjNt fz;%ly; iffhy; irj;jy; 
  fbe;Njhl;l Klf;fnyhL ePl;lnyd;Nd 
- a+fp rpe;jhkzp ghly; 245 
tsp NehahdJ Mdp> Mbapy; jd;dpiy tsHr;rpAk;> Ig;grp 
fhh;j;jpif khjq;fspy;  gpuNfhgKkhFk;.  
‘gJkj;ijg; g+f;f itf;Fk; ghDkpf;f fhAk; 
KJNtdp ypw;G tpw; ePh; Kw;Wk; - fJnkd 
tw;Wk; fgk‡Fk; thAkpFk; tho;khe;jh;f;  
  Fw;w eypf; Nfjpnjd; NwhJ” 
- kUj;JtH jdpg;ghly; 
KJNtdpw; fhyj;jpy;> #hpa ntg;gj;jpd; fhuzkhf ngUk; 
thhpahf ePh; Mtpahf;fg;gl;L G+kpapy; twl;rp epyTk;.  mJNghy; ekJ 
clypy; twl;rp Vw;gl;L tspNeha; tUtjw;F VJthfpwJ. 
czT kw;Wk; gof;ftof;fq;fs;: 
   ‘tspjU fha; fpoq;F tiutpyh japyy; Nfhio 
    Kspjaph; Nghd;kpFf;F Kiwapyh Tz;b Nfhly; 
    Fsph;jU tspapw; Nwfq; Fdpg;Gw Tyty; ngz;bh; 
    FspjU kaf;fk; ngw;Nwhh; fbnray; fUtpahkhy;” 
- rghgjp ifNaL 
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thj Fw;wj;ij kpifg;gLj;jf;$ba fpoq;F tiffs;> Fsph;r;rpia 
juf;$ba gjhh;j;jq;fs; kpFjpahf cz;zy;> Fsph;e;j fhw;wpy; ,Uj;jy;> 
kioapy; eidjy;> gdpf;fhw;W NkNy tpOjy;> kiyg; gpuNjrq;fspy; 
trpj;jy; kw;Wk; guk;giuapd; fhuzkhfTk; Njhd;Wk;. 
‘njhopy;ngW ifg;Gf; fhh;j;jy;> Jth;j;jy; tpQ;RfpDQ; NrhWk; 
  gioajhk; tuF kw;iwg; ige;jpid aUe;jpdhYk; 
  vopy; ngwg; gfYwq;fp ,utpdpYwq;fhjjhYk; 
  kio epfh; FoypdhNy thjq;Nfh gpf;Fq;fhNz” 
- guuhr Nrfuk; 
ifg;G> Jth;g;G> fhh;g;G gjhh;j;jq;fis kpFjpahf cz;zy;> gioa 
NrhW> tuF> jpid cz;zy;> gfypy; cwq;fp ,utpy; tpopj;jpUj;jy; 
Mfpa fhuzq;fspdhYk; thjk; kpFgLk;. 
‘nta;apypy; elf;ifahYk; kpfj; jz;zPh; Fbf;ifahYk; 
nra;apio kfspiur; Nrh;e;jD gtpf;ifahYk; 
igaNd cz;ikahYk; ghfw;fha; jpd;ifahYk; 
ijaNy thjNuhfk; rdpf;Fnkd; wwpe;Jnfhs;Ns” 
- Njiuah; thflk; 
#hpa ntg;gj;jpy; mjpf njhiyT elf;ifahYk;> mjpf jz;zPh; 
Fbj;jyhYk;> mjpfsT ghfw;fha; cz;ZtjhYk; mjpfsT fhkk; 
Ja;g;gjhYk; tsp Neha; Vw;gLk;. 
 
‘fhzNt kpfTz;lhYq; fUJgl;bdp tpl;lhYk; 
 khd;idahh; fz; Nkhfkwf;fpD kpFe;jpl;lhYk; 
 Mzt kyq;flk;ik aq;qNd tplhjjhYk; 
 thDjd; kley; yhNs thjq;Nfh gpf;Fq;fhNd” 
- guuhr Nrfuk; 
mjpf msT cz;zy;> gl;bdp fplj;jy;> Mztk; mjpfhpj;jy; 
Mfpatw;whYk;> 
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‘ghhpdpw; gag;gl;lhYk; gyUld; Nfhgpj;jhYk; 
fhnudf; fUjpNahbf; fOkuj; Juj;jpdhYk; 
Vh;ngW jdJ neQ;rpd; kpfj; Jf;fkile;jpl;lhYk; 
ghhpa fhw;wpdhYk; glhpDk; thjq;fhZk;”. 
- guuhr Nrfuk; 
        gak;> vy;NyhhplKk; Nfhgk; nfhs;sy;> kpFjpahf xly;> kpFe;j 
Jf;fk;> jpdKk; clypd;Nky; fhw;Wg;gly; Nghd;wtw;whYk;> 
  ‘fhyq;fz; khwpAz;Zq; fhhpaj; jhYe ;jz;zPh; 
  rhyNt aUe;jpdhYe; re;jpYl; fhh;e;jhYk; 
  Nfhykhk; Gspg;G nea;ia tUe;jpdhYk; 
  thy;thh; Kiy ey;yhNs thj Kw;gtpf;Fq;fhNz” 
- guuhr Nrfuk; 
‘vd;dNt thjk; jhndz;gjhFk;  
  kpfj;jpNy kdpjh;fSf;F nra;JkhW 
 gpd;dNt nghd;jidNa Nrhuq;nra;J> 
  nghpNahh;fs; gpuhkziuj; J}~zpj;Jk;> 
 td;Njtw; nrhj;jpr; NrhuQ; nra;J  
 khjh gpjh FUit kwe;j Ngh;f;Fk; 
 fd;dNt Ntfj;ij epe;ij nra;jNgHf;Fq; 
  fhaj;jpw; fye;jpLNk thje;jhNd” 
- A+fp rpe;jhkzp ghly; 243 
‘jhndd;w frg;NghL Jth;Giwg;G  
  rhjfkha; kpQ;RfpDQ; rikj;j tz;zk; 
 Mndd;w thwpdJ nghrpj;jyhYk; 
  Mfhaj; NjwyJ Fbj;jyhYk; 
  ghndd;w gfYuf;f kpuhtpopg;G 
  gl;bdpNa kpfAWjy; ghunka;jy; 
 Njndd;w nkhopahh;Nks; rpe;ijahfpy; 
  rPf;fpukha; thjkJ nrdpf;Fe;jhNd” 
- A+fp rpe;jhkzp ghly; 244 
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jha;> je;ij> FU> ,th;fis kwj;jy;> Ntjj;ijg; gopj;jy;> frg;G> 
Jth;g;G> ciug;G Nrh;e;j czit mUe;jy;> Mwpd czit cz;zy;> 
Njq;fpa ePh;> yhfphpahd fs;> rhuhak; Fbj;jy;> gfypy; J}q;fp ,utpy; 
tpopj;jpUj;jy;> mjpfkhf gl;bdp fplj;jy;> kpFe;j Rikiaj; J}f;Fjy;> 
ngz;zpd; Nky; rjh epidg;Gf; nfhs;sy; Mfpa fhuzq;fshy; thj 
Neha; cz;lhFk;. 
Rit: 
 ‘GspJtH tpQ;Rq;fwp ahw;G+rpf; Fk;thjk;> 
 Xsp AtHifg; Ngwpy; gpj;Jr; rPWk; - fpspNkhopNa 
 fhHg;gpdpg;G tpQ;rpw; fgk;tpQ;R Q;rl;bujr; 
 Nrug; GzH NehaZfhNj”. 
 vd;gjpdhy;> Gspg;G> JtHg;G mjpfKs;s czTfshy; thj 
kpFjpg;gLk;. 
MkNjhlk;: 
  ‘NghNkjhd; ur J}\paj; jpdhNy 
   nghy;yhj ,e;jNeha; fhZk; ghU 
  ehNkjhd; Koq;fhy;fs; nghpa fPy;fs; 
   ed;ikAld; mijr; Rw;wp ,Uf;Fk; rt;tpd; 
  fPNkTk; rt;Tf;F typfs; fz;lhy; 
   rpwg;ghf ,e;Neha;fs; tUFk; ghNu” (538) 
       -  mfj;jpaH Fzthflk; 
,g;ghlyhy; MkNjhlj;jpdhy; fPy;fis jhf;Fk; Neha;fs; 
cz;lhFk; vd;W mfj;jpaH $WfpwhH. 
 
kw;w Neha;fspd; gpd; tpisT: 
  ‘njhy;iy nra;a ,d;Wk; ntF thj Neha;fs; 
   njhy;Yyfpy; khe;jUf;Ff; fhz;gJz;L 
  vy;iyapy;yh thjNeha; NeHikjd;id 
   ,ay;ghf mwpe;jplNt tpguq;NfNs”. 
        - ghly; 215 
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  ‘tptuklh mrjprd;dp KisNehT 
   tphpthd KisaJ kpUJthfp 
  mtdpjdpy; jplkhfg; NghtjhYk; 
   mg;gNd Kj;jpuf; Fz;bf;fha; tpahjpahYk; 
  jtKdptH jPHfhq;if NkfNuhfk; 
   jd;ikAs;s Kj;jz;Lf; nfhbtpahjp 
  mtkpyg; ghpr euk;gOj;jq; fz;lhy; 
   fZFklh thjNeha; MFk;ghNu” 
        - ghly; 218 
 
  ‘mZFklh khkprj;jpd; tpahjpahYk; 
   mg;gNd #jj;jpd; ngUf;fhYk; 
  Fzkpy;yh ,urk; tq;fk; jpd;dyhYk; 
   FbnfLj;j thjkJ cz;ghkg;ghH”. 
        - ghly; 223 
       - mfj;jpaH Fzthflk; 
 rd;dp> %isNeha;> gpUf;f Neha;fs;> Nkfk;> jz;Ltl Neha;fs;> 
#jk;> tq;fk; Mfpa kUe;Jfis KiwNflhf gad;gLj;JtjhYk; 
thjNeha;fs; cz;lhFk;. 
mff;fhuzk;: 
 Nfhs;fSf;Fk; gpzpfSf;Fk; cs;s xg;Gik - 
‘$Wnkhd;W %d;Wld; FyT ehiye; NjopYk; 
  Fw;wkhk; eyj;jpDk; nfh^uk; gd;dpuz;bYk;  
  NruNt Gjd;jhWNkh rPhpaNkid epd;wpby;  
  nrg;nghzhj jPikNahL nra;Ak; gr;re;jhWk; 
  neLe;Jf;f kpf;fthk; elf;fe;jhJ njhopy; jhk; 
  epe;ijahF fPy;gpbg;G ePL nka;apy; Njhd;Wkhk; 
   fhhpaq;fs; Nrjkha; fhy;taJ FiwAkhk; 
  fz;Lzh;e;J fzpj ty;Nyhd; fUj;Jld; nrg;gpdNu.” 
     - kzpke;jpu itj;jpa Nrfuk;. 
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 fpufhjpfs; kf;fspd; nrd;khe;jpu ey;tpid jPtpidfNfw;g 
mikANk my;yhky; NtWtpjk; Mfh. mt;tpidg; gadpd; fhhpaNk 
gpzp. ,JTk; fUtpy; mikg;G. fPy;gpbg;G Kjypa thj Neha;fs; cz;lhf 
fpuf epiyfSk;> Nfhs;fSk; fhuznkd kzpke;jpu itj;jpa E}y; 
$wpAs;sJ. 
‘E}nyd;w thjk; te;j tifjhNdJ 
 jd;ikaha;f; fd;kj;jpd; tifiaf; NfS 
 fhypNy Njhd;wpaJ fLg;gNjJ 
 iffhypy; Klf;fpaJ tPf;fNkJ 
 NfhypNy gLfpd;w tpUl;rkhd 
 Foe;ij kue;jid ntl;ly; Nky;Njhy; rPty; 
 ehypNy rPtIe;J fhy; Kwpj;jy; 
 ey;ynfhk;G jioKwpj;jy; eypj;jy; jhNd” 
- mfj;jah; fd;kfhz;lk; 
kdpjdpd; fd;k tidapdhy; fhy; fLg;G> if fhy; Klf;F tPf;fk; 
Kjypad cz;lhFk; fd;k tpidahdJ tsUk; kuj;jpid rpijj;jy;> 
rPt re;Jf;fspd; fhy; Kwpj;jy;> nfhk;G jio Kwpj;jy; Mfpatw;why; 
cz;lhFk;   
Neha; tUk; top 
taJ 
czT 
gof;ftof;fq;fs; 
fhykhWghL 
 
  gpj;jk;   thjk;  fgk; 
  rhjfk;  tpahdd;  re;jpfk; 
     mghdd;   
 
moy; fPy;thA 
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moy;fPy; thA  
Neha; FwpFzq;fs;  
‘gpj;j fPy;thA jd;dhw; gpwq;F fPy;%l;L tPq;fpr; 
rpj;jh; nra; kUj;Jtj;JQ; rPh;glhjd;ikj;jhfp 
jj;jW fha;r;ry; fz;L rhyNt jidjhd; je;Nj 
nkj;jw rpfpr;ir jd;dhy; nkd;Nky; ePf;Fkg;gh” 
- rghgjp ifNaL. 
¾ Kl;bfspy; cz;lhFk; tPf;fk;. 
¾ jPf;Fw;w kpFjpahy; fPy;fspd; gir twz;L> khraw;W fPy; 
mirAk; Nghnjy;yhk; xyp cz;lhFk;. 
¾ rpy Ntisfspy; fPy;fspYs;s nghUj;Jfs; 
xd;nwhnlhd;W xl;bf;nfhz;L klf;f KbahkNy 
epd;WtpLk;. 
Koq;fhy; thjk;: 
‘jpuz;bL Koq;fhy; tPq;fpr; Nrunehe; Jise;J Fj;jpg; 
 Guz;bl klf;fp kpz;bg; NghjNt eilnfhlhJ 
 kUz;LNty; fizkh dk;G thnsd kpspUq; fz;zha; 
 Kuz;lU Koq;fhy; jd;dpd; nkhope;jpL thjkhNk” 
       -guuhr Nrfuk; 
¾ Koq;fhy;fspy; tPf;fk; typ elg;gjpy; rpukk; fhzg;gLfpwJ. 
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Kf;Fw;wq;fs;  
thjk;: 
G+jk;   -  tsp + tpz; 
jd;ik  -  ntg;gk;> $H;ik> nea;g;G> nefpo;r;rp> ,af;fk;  
thOkplk; -  mghdd;> kyk;> ,lfiy> ce;jpapd; fPo;%yk;>  
,Lg;G> vYk;G> Njhy;> euk;Gf;$l;lk;> fPy;fs;> 
kapHf;fhy;> Cd;> 
,aw;ifg; gz;G -  Cf;fKz;lhf;fy;> %r;R tply;> thq;fy;>  
kdnkhopnka;fSf;Fr; nraiyj;juy;> kyk; 
Kjypa gjpdhd;F tpiuTfis 
ntspg;gLj;jy;> rhuk; Kjypa VO 
clw;fl;Lfl;Fk; xj;j epfo;r;rpiaj; juy;> 
Ik;nghwpfl;F td;ikiaf; nfhLj;jy;. 
nra;njhopy;  -   cly; Nehjy;> Fj;jy;> gpsj;jy; nghy; fhzy;>  
euk;G Kjypad eLf;fy;> ,Wf;fkhjy;> 
epHg;girapd;ik> mirj;jy;> if> fhy; ,lk; 
tpl;Lk; ngaHj;jy;> cWg;Gj; jsHr;rp> 
Fzk;: 
 
‘thjj;jpd; FzNk njd;dpy; kaf;Fe; jpaf;Fk; kyHrptf;Fk; 
ghjq;FspHe;J rUthq;fk; gw;wp elf;f Kfq;fLf;Fk; 
rPjj;JlNd tapW Gz;zhFk; rphpg;gpj;jJe; njwp%r;rhk; 
Nghjj; jz;zPHjhd; thq;Fk; GfOk; gQ;r FzkhNk 
thjj;jpd; Fzj;ijf; Nfz;kpd; tapWhJk; nghUkpf;nfhs;Sk; 
jhJw;w Tlk;G iffhy; re;Jfs; fLg;Gj; Njhd;Wk; 
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fhy;if fLf;Fe; jpkpUz;lhq; fz;Ze; J}q;fpr; Nrhgpf;Fk; 
NfhyQ; nrhpAkq; fnky;yhq; FspHe;J re;J fdq;nfhs;Sk; 
rPy kpFe;J rPH fhzpy; rpWePH tw;wp tUkpfNt 
khyj; jlq;fz; khdidahy; khNj thj NuhfkpNj” 
       -mfj;jpaH 2000 
‘thjj;jpd; FzNk jd;dpy; 
tapW nghUkpf; nfhs;Sk; 
jhfj;jpy; Nkdp iffhy; 
re;JNk fLg;Gj; Njhd;Wk;’ 
    - Fwpailahs ehb 
kaf;fk;> fz;fs; rptf;Fk;> ghjk; FspWk;> tapW CJk; if fhy; 
fLg;G Njhd;Wk; tapW Gz;zhf;Fk;> re;Jfs; NjhWk;> fLg;G Njhd;Wk; 
rPWePH tw;Wk;. 
gphpTfs;: 
1. gpuhzd; (capHf;fhy;) - %r;R tpLjYk;> thq;FjYk; nra;Ak; 
2. mghdd; (fPo;Nehf;Ffhy;) - kyryj;ijf; fPo; Nehf;fpj; js;Sk; 
3. tpahdd; (guTfhy;) - clypYs;s mirAk; nghUs;> mirahg; 
nghUs; vd;Dk; ,uz;bYkpUe;J cWg;Gfis ePl;lTk; 
klf;fTk; nra;aTk;. 
4. cjhdd; (Nky; Nehf;Ffhy;) - the;jpia vor; nra;Ak;. 
5. rkhdd; (eLf;fhy;) - kw;w thAf;fis kQ;r nthl;lhky; 
nra;Ak;. 
6. ehfd; - vy;yhf; fiyfisAk; fw;Fk;gb mwpit vOg;Gk;. 
fz;fis ,ikf;Fk;gb nra;Ak;. 
7. $Hkd; - nfhl;lhtp tplr;nra;Ak;> thia %lg;gz;Zk;> 
,ikiaf; nfhl;Ltpf;Fk;. fz;fSf;Fg; nghUl;fisf; 
fhz;gpf;Fk;. 
8. fpUfud; - ehtpw; frpT> ehrpf;frpT> kpf;f grp> Jk;ky;> ,Uky; 
Mfpatw;iw cz;lhf;Fk;. 
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9. Njtjj;jd; - Nrhk;gy;> rz;il nfhs;sy;> jHf;fk; Ngry;> kpf;f 
Nfhgk; Mfpatw;iw cz;lhf;Fk;. 
10. jdQ;nrad; - clk;G KOikAk; tPq;fg;gz;Zk;> ,we;Jtpbd; 
fhw;nwy;yhk; ntspg;gl;l gpd;dH %d;whtJ ehspy; jiy 
ntbj;jgpd; ntspr; nry;Yk;. 
thjk; kpF Fzk; 
 
 ‘mwpAk; thjj;jpy; mLj;j gpj;jkhapd; 
   FwpaJjhd; thAk; FoWk; newpahy; 
   FspUq; fhy; tPq;Fk; Fly; Gwl;Lk; tpk;kpj; 
   njsptpy;iy Gj;jpnadr; nrg;G” 
    -fz;Zrhkpak; vd;Dk; itj;jpa Nrfuk; 
 
‘nrhy;yNt thjkJ kPwpw;whdhy; 
Nrhh;tile;J thAtpdhy; Njfnkq;Fk; 
nky;yNt if fhy;fSf; frjpAz;lhk; 
nka;Klq;Fk; jpkunthz;zhj; jpkpUz;lhk; 
ty;yNt Aly; nghUKk; tapWisf;Fk;  
tpUk;gp ad;dr; nry;yhJ tpe;J e\;lk;  
nfhs;sNt ehg;Gspf;Fk; fopr;rYz;lhk; 
$wpdhh; kiyKdp $wpdhNu”. 
 
‘thjNk fjpj;jNghJ thATnkOk;Gq; fz;Bh; 
thjNk fjpj;jNghJ te;jpLQ; rd;dp Njh\k; 
thjNk fjpj;jNghJ ty;Yld; nkype;J nfhy;Yk;” 
- mfj;jpah; rpfpr;rhuj;d jPgk; 
thjk; kpFe;jNghJ thA kpFk;> rd;dp Njhlk; Nghd;w gy 
tpahjpfs; te;J NrUk;> cly; nkypAk;. thjk; kpFk;NghJ cly;nkypT> 
cly;Nrhh;T> if fhy; mrjp> clypy; jpkpUz;lhjy;> tapw;W nghUky;> 
fopr;ry;> tpe;J e\;lk;> ehit Gspf;fr; nra;jy; Nghd;w Fzq;fs; 
cz;lhFk;. 
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‘mwpatpk; %d;wpd; jd;ik nrhd;dhh;ee;jp 
  vwpa ey;thj nkwpf;Fq; Fzq;NfS 
  Fwpnadf; iffhy; Fisr;R tpyhr;re;J 
  gwpnad nehe;Ekw; gr;ir Gz;zhFNk 
  Gz;zha; typf;Fk; nghUKk; FlNyhbj; 
  jz;zh kyj;ijj; jk;gpf;Fk; Nghf;fhJ 
  xz;zh MrdKwNt Ruf;fpLk; 
  kz;zhh; Fsph;rPLk; gUj;jpLk; thjNk” 
- jpU%yehadhh; rpfpr;rhuj;djPgk; 
thj Nehapy; cisr;ry;> tpyhr; re;Jfs; Nehjy;> tapW nghUky;> 
Flypiwr;ry;> kyr;rpf;fy; Nghd;w FwpFzq;fs; Njhd;Wk;. 
‘thjtPW md;dkpwq;fhJ fLg;Gz;lhk; tz;zKz;lhk; 
 NkhJfl;F Nuhfk; RuKz;lh kpUkYkh Kwq;fhnjd;Wk; 
 XJjhpa thjkdyhF eLf;fKz;lhk; nghUs; fsah;e;j 
 jPnjdNt euk;gpj;J re;Jfs; NjhWq;fLf;Fe; jpdKe;jhNd” 
- Njiuah; thflk; 
thjk; kpFk;NghJ grpapd;ik> cly; fLg;G> Ruk;> ,Uky;> 
cwf;fkpd;ik> cly; eLf;fk;> euk;Gj;jsh;r;rp> re;Jfs; NjhWk; Filjy; 
Nghd;w FwpFzq;fs; Njhd;Wk;. 
‘jf;f thA Nfhgpj;jhy; re;Jise;J #iyNehth  
   kpf;f nfhl;lhtp tpl;lq; nfhpA kyq;nfl;Lk; 
   xf;f euk;G jhd; Klq;F kyh;e;J tha; eP&wptUk; 
   kpf;f FspUk; eLf;fkha; Nkdp Fd;wp tUq;fhNd” 
- Njiuah; thflk; 
thjk; kpFk;NghJ %l;Lfspy; typ> kpFe;j nfhl;lhtp> kyr;rpf;fy;> 
euk;Gj;jsh;r;rp> tha; ePUwy;> kpff;Fsph;r;rp> cly; eLq;fy; Nghd;w 
FwpFzq;fs; Njhd;Wk;.  
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gpj;jk;: 
G+jk;   -  jP 
jd;ik  - ntg;gk;> $Hik> nea;T> nefpo;r;rp>  
,af;fk;. 
thOkplk;  - gpq;fiy> gpuhzthA> ePHg;ig>  
%yhf;fpdp> ,Ujak;> jiy nfhg;G+o;> 
ce;jp> ,iug;ig> tpaHit> ehtpYWfpd;w 
ePH> nre;ePH> rhuk;> fz;> Njhy;. 
,aw;if gz;G - nrhpg;gpj;jy;> grpePH Ntl;if> ghHit>  
Rit> mwpT> ntk;ik mspj;jy;. 
nra; njhopy; - cly; ntg;gk; cz;lhjy;> czit  
nrhpf;f nra;jhy; tpaHj;jy;> kaf;fk; 
Vw;gly;> nre;ePH jd; mstpy; kpFjy; 
mt;thW kpFe;j nre;ePH ntspg;gLjy;> 
Njhy;> fz; kyk;> rpWePH Kjypad 
kQ;rs; epwkiljy;> rPw;wk;> 
tzf;fkpd;ik> mirtpd;ik> epidT> 
ntwp> nkypT> vhpT cz;lhTjhy;. 
gphpTfs;: 
1. mdw;gpj;jk; - cz;l czTg; nghUl;fisr; nrhpf;Fk;gbr; 
nra;Ak;. 
2. ,uQ;rfg; gpj;jk; - cztpypUe;J gphpe;Jz;lhd rhw;Wf;Fr; 
nre;epwj;ijj; jUk; 
3. rhjfg; gpj;jk; - tpUg;gkhd njhopiyr; nra;J Kbf;Fk;. 
4. gpuhrfk; - NjhYf;F xspiaf; nfhLf;Fk; 
5. MNyhrfk; - fz;fSf;Fg; nghUs;fisj; njhptpf;Fk;. 
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fgk;: 
 G+jk;   -  ePH + kz; 
 jd;ik  -  jz;ik> nea;g;G> ke;jk;>  
tOtOg;G>nkd;ik> jpz;ik. 
thOkplk;  -  rkhdthA> RopKid> ntz;zPH>  
Mf;fpiz> ehf;F> nfhOg;G> kr;ir> 
FUjp> %f;F> khHG> euk;G> vYk;G> %is> 
ngUq;Fly;> fz;> fPy;fs;. 
 ,aw;ifg; gz;G -  fPyfspd; mikg;gpd; fl;Lfs;>  
nghwikAilik. 
 nra;njhopy;  -  gUj;jy;> vd;gpy; vNjh G+rg;gl;lJ  
Nghd;w czHr;rp> fPy;fs;> njhopy; 
GhpahjpUj;jy;> nrhpahik> kpFJ}f;fk;> 
Njhy;> fz;> kyk;> rpWePH> 
ntz;zpqkiljy;. 
gphpTfs;: 
1. mtyk;gfk; - ehd;F tif Iaq;fSf;Fk; gw;Wf; 
NfhlhapUf;Fk;. 
2. fpNyjfk; - cz;zg;gl;l czTg; nghUs;> ePH 
Kjypaitfis <ug;gLj;jp nkj;njdr; nra;Ak;. 
3. Nghjfk; - cz;Zfpw Ritfis mwptpf;Fk; 
4. jw;gfk; - fz;fSf;Ff; FspHr;rpiaj; jUk;. 
5. re;jpfk; - nghUj;Jfspy; epd;W ,aw;ifaha; vy;yhf; 
fPy;fisAk; xd;Nwhnlhd;W nghUj;jp jsur; nra;Ak;. 
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Kf;Fw;w NtWghL: 
 tsp vd;Dk; thAthdJ XH cUtg; nghUs; my;y. cUtg; 
nghUsha;j; Njhd;whky; jdJ ,aq;Fk; jd;ikahy; czug;gLtjhy; 
njhopiy cUtg; nghUs;fspd; kPJ fhl;Lfpd;wJ. mJ vd;G> Cd;> 
euk;G vd;w gpUjptpf; $Wg; nghUs;fspYk;> ,urk;> ,uj;jk;> FUjp> 
vd;Dk; mg;Gf; $Wg; nghUs;fspYk;> mf;$Wfs; fyg;Gs;s 
nghUs;fspYk; NrHe;J jdJ kPwpakhWghl;ilj; Njhw;Wtpj;J 
mt;TWk;ig> tPq;fy;> typj;jy;> njhopyw;Wg; Nghjy;> G+l;Lfs; eOTjy;> 
vU fl;Lg;gly; Kjypa FwpFzq;fis Vw;gLj;Jk;. 
kpFe;j thAthdJ: 
1. nfhOg;igg; gw;wpd;: iffhy;fspy; typ> Fj;jy; Mfpa 
tUj;jq;fis Vw;gLj;Jk;. 
2. Cidg; gw;wpd;: cly; fdg;G> jbahy; mbj;jy; Nghd;w typ 
cz;lhf;Fk;. 
3. vd;igg; gw;wpd;: vYk;ig Klf;fYk;> ntk;ikAk; Vw;gLj;j 
mt;ntYk;Gfspd; kPJs;s rt;TfspYk;> NgrpfspfspYk; 
jhf;fp> jir ehWfspd; td;ikiaf; Fd;wr; nra;Ak;. 
4. %is(kr;ir)iag; gw;wpd;: vYk;Gfs;> fZf;fs; 
gpsf;fg;gLtJ Nghd;w tUj;jKk;> jir kw;Wk; jir ehWfs; 
td;ik ePq;FjYk;> J}f;fkpd;ikAk; Vw;gLj;Jk;. 
5. G+l;Lfs; my;yJ re;jpfisg; gw;wpd;: G+l;Lfspy; Klf;fTk;> 
ePl;lTk; Kbahjgb td;ikAz;lhf;Fk;. 
6. rt;Tfisg; gw;wpd;: rt;Tfspy; fye;Js;s cWg;gpd; ,aw;if 
cUtj;jpw;F Ntw;Wikia cz;lhf;Fk;. 
vd;Gk; %l;Lk; thjk; thOkplkhFk;.  Mjyhy; elf;f> Xl thjNk 
fhuzkhfpwJ.  moy;fPy; thAtpy; thjk; ghjpf;fg;gl;L mjdhy; 
tpahdd;> mghdd; ghjpf;fg;gLfpd;wJ.   
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tpahdd; ghjpf;fg;gLtjhy; typ> %l;Lfis mirf;f rpukk;> 
mghdd; ghjpf;fg;gLtjhy; kyr;rpf;fy; Mfpad Vw;gLfpwJ. 
rkhdd; ghjpf;fg;gLtjhy; nrhpahik kw;Wk; kw;w thAf;fisAk; 
NfL Mfpatw;iw cz;lhf;FfpwJ. 
Njtjj;jd; ghjpg;giltjhy; J}f;fkpd;ik Vw;gLfpwJ. 
thjj;Jld; fgk; - re;jpfk; ghjpf;fg;gl;L %l;L mirTfspy; 
khw;wk; Vw;gLfpwJ. 
filrpahf gpj;jk; ghjpf;fg;gl;L rhjfkhd gzpfisr; nra;a 
KbahkyhfpwJ. 
 
thjk; 
Kjy; epiy ghjpg;G tpahdd; - Kl;Lfis mirf;f rpukk; 
mghdd; - kyr;rpf;fy; 
rkhdd; - kw;w thAf;fspd; NfL 
Njtjj;jd; - J}f;fkpd;ik 
         
,uz;lhk; epiy ghjpg;G   
  fgk;            gpj;jk; 
  re;jpfk;            rhjfk; 
   Kl;L mirTfspy; khw;wk;      rhjfkhd gzpfis  
 mtyk;gfk;          nra;tjpy; Klf;fk;   
   re;jpfk; ghjpg;G       
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VO clw;jhJf;fspd; ghjpg;G:  
 rhuk;  ghjpg;gile;J kdr;NrhHT> clw;NrhHT Vw;gLfpd;wJ.  
Cz; ghjpg;giltjhy; Neha; Kw;Wk; NghJ Ngrp #k;gy; 
fhzg;gLfpwJ. 
nfhOg;G ghjpg;giltjhy; %l;Lfspd; typ Vw;gLfpd;wJ 
vd;G ghjpg;gLtjhy; %l;Lfs; nra;ygLtjpy; rpukk; 
fhzg;gLfpwJ. 
%is ghjpg;giltjhy; %l;Lfspy; tPf;fk;> typ fhzg;gLfpwJ. 
 
fhyepiyfspy; Kf;Fw;wk;: 
 
KJNtdpw; fhyj;jpy; ekJ clypy; twl;rp Vw;gl;L tspNeha; 
tUtjw;F VJthfpwJ. 
gQ;r G+jq;fspd; NtWghL: 
 ‘jyq;fhl;bape;jr; rlkhditk; G+jk; 
 epyq;fhl;b ePHfhl;b epd;wpLe;jPfhl;b 
 tyq;fhl;b thAthy; tsHe;NjapUe;jJ 
 Fyq;fhl;b thdpw; FbahapUe;jNj 
       - jpU%yH ehb 
,t;Tyfk; gQ;rG+j kakhdJ. 
 
jd;dpiy 
tsh;r;rp 
Ntw;Wepiy 
tsh;r;rp 
jd;dpiy 
miljy; 
thjk; KJNtdpy; fhh;fhyk; $jph;fhyk; 
gpj;jk; fhh;fhyk; $jph;fhyk; Kd;gdp 
fgk; gpd;gdp ,sNtdpy; KJNtdpy; 
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clypy; gQ;rG+jk;: 
 ‘Nrug;gh rlkhr;R kz;zpd;$W> 
  nrwpkapH Njhy; vYk;gpiwr;rp euk;ige;jhFk; 
 Neug;gh mg;Gtpd; $Wjpukr;ir 
  ePH %is Rf;fpyNkhl Q;rhFk; 
 rhug;gh jPf;$W gakhq;fhuq; 
  fLQ;Nrhg;G epj;jpiu ikJdq;fsQ; Nr 
 mQ;rhd thAtpd; $wpUe;jNyhky; 
  ait elj;jhy; fplj;jYldpw;wyQ;rhk; 
 mQ;rhFkhfh rf;$W fhkkjpw;FNuhjk;> 
  cNyhg Nkhf kjkQ;rhFk;”. 
- rjf ehb 
vd;gjpdhy; 
1. kapH> Njhy;> vd;G> Cd;> euk;G Mfpad kz;zpd; $W 
2. rhuk;> FUjp> rpWePH> %is> Rf;fpyk; Mfpad ePhpd; $W. 
3. gak;> Mq;fhuk;> Nrhk;gy;> epj;jpiu> ikJdk; Mfpad jPapd; 
$W 
4. ,Uj;jy;> Xly;> elj;jy;> fplj;jy;> epw;wy; Mfpad thAtpd; 
$W. 
5. fhkk;> FNuhjk;> Nyhgk;> Nkhfk;> kjk; Mfpad Mfhaj;jpd; 
$W.  
gQ;r G+jq;fspd; khWghlhf moy; fPy;thA Nehapy; kz;zpd; 
$Wfshd vd;G> Cz; ghjpg;gilfpd;wJ> kw;Wk;> %is (ePhpd; $W) 
ghjpf;fg;gLtjhy; Xly; elj;jy; (thAtpd; $W) ghjpg;gilfpd;wJ.  
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jpiz (Geographical distribution) 
FwpQ;rp -  kiyAk; kiy rhh;e;j gFjpAk; 
Ky;iy  -   fhLk; fhL rhh;e;j gFjpAk; 
 
‘Ky;iy eye;jaNk %hpepiu NktpDkt;  
nty;iy epiyj;jgpj;j nkq;FWq;fhz; - ty;iynadpd; 
thjnkhop ahjjDz; kd;D kittopNehag; 
Ngjnkhop ahjiwag; gpd;G”   
- gjhHj;j Fz rpe;jhkzp 
 
kUjk;   -   taYk; tay; rhh;e;j gFjpAk; 
nea;jy;  -   flYk; fly; rhh;e;j gFjpAk; 
 
 
 ‘nea;jdpy; NkYg;ig ePq;fh JwpDkJ 
 nta;jdpy Nkjq;F tPlhFk; - nea;jy; 
 kUq;Fliy kpf;fhf;Fk;;: ty;YWg;ig tPf;Fk;> 
 fUq;Fliyf; fPopwf;Fq; fhz;” 
 - gjhHj;j Fz rpe;jhkzp 
 
ghiy  -   kzYk; kzy; rhh;e;j gFjpAk; 
Ky;iy kw;Wk; nea;jy; epyq;fspy; thjNeha;fs; ngUkstpy; 
Vw;gLk;. 
cly; td;ik (Body Built) 
1. ,aw;if td;ik - gpwtpapNyNa jUtpg;gJ 
2. fhy td;ik  - tajpy; jUtpg;gJ 
3. nraw;if td;ik  - czT gof;f tof;fq;fspdhy; jUtpg;gJ 
moy;fPy; thAtpy; czT gof;f tof;fq;fs; kw;Wk; taJ 
Nghd;wit Kf;fpa gq;F tfpf;fpd;wd.  MfNt nraw;if td;ikAk;> 
fhy td;ikAk; ghjpf;fg;gLfpd;wd. 
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ahf;if: 
 clypd; czthjp nray;fshy; Kf;Fw;wq;fSs; vJ kpFjpg;gl;Lf; 
fU cw;gj;jpapy; Rf;fpy RNuhzpjk; fyf;fpd;wNjh> mf;Fw;wNk Kjw; 
fhuzkhapUe;J ahf;ifia mikf;Fk;. ahf;if 9 tifg;gLk;. 
ahf;if 9 tifg;gLk;. 
1. thjk; - fUik> nrk;ik epwk;> mw;gTz;b> tha;Tg; ngUf;fk;. 
2. thjgpj;jk; - fUik epwk;> mjpf grp fbe;jnkhop Kd;Nfhgk;> 
ngha;AlNd nka;AQ; nrhy;Yk;. 
3. thj rpNyj;kk; - tz;zKWk; nrk;ik epwk;> ,bNghy; Fuy;> mjpfk; 
grp> fiyQhdk; mwpT fhZk;. 
4. gpj;jk; - nts;is epwk;> mw;gTz;b> Fog;gk;> tPuk; fhZk;. 
5. gpj;j thjk; - nghJ epwk;> Fapy;Nghy; Fuy;> NeHik ,wf;fk;> fhZk;. 
6. gpj;j fgk; - nrz;gfg;G+ epwk;> thj;jpaFuy;> kdj;jplk; fpUig 
nghpNahiu NgDk;. 
7. fgk; - rpte;j Nkdp> ,bNghy; Fuy;> mw;gg; grp> ngha;aij nka;aha; 
ciuf;Fk;. 
8. fgthjk; - fUik nrk;ik epwk;> nghpNahiu Nghw;Wjy;> md;G> Nerk;> 
fhZk;. 
9. fggpj;jk; - NfhNuhrid epwk;> ntbf;Fuy;> Nahfk;> gzpT> gz;G> 
tPuk;> fhZk;. 
 ngUk;ghYk; moy; fPy;thA thjgpj;j kw;Wk; gpj;j thj 
NjfpfSf;F fhzg;gLfpwJ. 
thj gpj;j Njff; Fwp 
 ‘jhdKw thjj;jpy; gpj;jQ; Nrh;e;jhy; 
  rhPuFwp nkypT epwq; fUg;NgahFk; 
 <dKwg; ngha;AlNd nka;AQ; nrhy;Yk; 
  vhpg;GNlNd Jth;g;gjpf Kz;z Ntz;Lk; 
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fhdkUq; Foyhh;Nky; kpFe;j thir 
   fbe;j nkhop Kd; Nfhgk; fhl;L Ks;sk; 
 MdTly; nebjyJ Fwpj;jyhFk; 
  mwpT Fiwe;jpUf;Fnkd twpayhNk” 
        - Neha;ehly; I 
vd;gjpdhy; thjgpj;jj;jhnyLj;j Njfk; fWik epwk; ngha;Ak; 
nka;Ak; fye;J Ngry; mwptpd;ik Kd;Nfhgk; fhuk; Jth;g;G Ritapy; 
mjpf ,r;irAKd;lhk; 
gpj;j thj Njff; Fwp: 
 ‘cwthd gpj;jj;jpy; thjQ;Nrh;e;J 
  Twe;njOj;j NjfkJ nghJ epwNkahFk; 
 epiwthd Fzq;fpUig fhl;irthkk; 
  Neh;ik Rfpad;Fspif Nahfkha;if 
 Kwthd fdT ew;fe;jk; Ntz;Lk; 
  tha;Qhdkjpg;Gj;jp Fapy;Nghy; thh;j;ij 
 JwthdTly; twl;rp grp nghWikahFk; 
  #nlhpg;Gg; Gspg; gjpfKz;ZQ; nrhy;iy” 
- Neha;ehly; I 
vd;gjpdhy; gpj;jthjj;jhnyLj;j Njfk; nrk;ik my;yJ 
ntz;ik epwk; mwpTilik Njftwl;rp Kjypa Fzq;fNshL fhuk; 
Gspg;G Ritfspy; Mtyjpfk; vd;gdthk; 
Neha; epjhdk; (Differential Diagnosis) 
tspfPy; thA 
‘typf;Fj;jy; tPf;fq;fhZk; tha;j;njhz;il twl;rp fha;r;ry; 
jiy typ khHJbg;Gj; jhq;nfhzh typ tPf;fe;jhd; 
epyT fhq;fZf; Fwq;F ePL Njhs; Koq;iff; fhw;fhk; 
kyf; Flw;fl;L NtHit thjf;fPy; thA tpjhNk” 
       - rghgjp ifNaL 
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jhq;f Kbahj typ> fhy; tpuy;> Koq;fhy; %l;L> ,Lg;G %l;L> 
Koq;if %l;L> Njhs; %l;L Mfpa %l;Lfspy; tPf;fk;> tha; twl;rp> 
Ruk;> jiytyp> glglg;G> kyr;rpf;fy;> tpah;j;jy; Mfpa 
FwpFzq;fisAilajhFk;. 
Iaf;fPy;thA 
 ‘fUjUq; fgf;fpy; thA fz;bbd; clypisf;Fk; 
 cUnkypthf;Fq; nfhs;Sk; cz;biar; RUf;F kpdge; 
 jUJapy; ePq;F Kl;bw; whq;nfhzh tYitahf;Fk; 
 ,UkNy tpf;fy; the;jp> Nrhig ghz;nlOg;Gk; ghNu”. 
- rghgjp ifNaL 
 
%l;Lfspy; jhq;f Kbahj typ> cly; nkypT> grpapd;ik> tpf;fy;> 
the;jp> ghz;L Mfpa FwpFzq;fs; fhl;Lk; NehahFk;. 
tsp IafPy; thA 
 ‘mitak; thjf; fgf;fPy; thAthd; typ kpFe;Nj 
 caq;F ePH Nfhj;J fPy;fs; Xhpapd; jiyNghw; fhZk; 
 eaq;nfhs;s Klf;fy; ePl;ly; ez;zplhnka;Aq;fhAk;> 
 kaf;FW Kwf;fkpd;dhk; kd;dpa nehpf;fl;lhNk”. 
- rghgjp ifNaL 
 
%l;Lfspy; typ> tPf;fk;> mirf;f rpukk;> Ruk;> J}f;fkpd;ik> 
Mfpa FwpFzq;fSld; Koq;fhy; %l;by; ehpapd; jiyNghy; tPf;fk; 
fhZk;. 
re;J thjk;: 
 fPy;fs; NjhWk; jpkpHe;J> clnyq;Fk; nehe;E mod;W kapHf; 
$r;nrwpAk;> elf;f Kbahik> kaf;fk;> tha; ePUwy;> ehtwl;rp Kjypa 
FwpFzw;fisAz;lhf;Fk;. iffhy;fs; epyj;jpw;gbahjthW 
Jd;GWj;Jk;. 
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gpzpawpKiwik: 
vz;tifj; Njh;Tfs;:  
‘Neha;ehb Neha;Kjy; ehb mJ jzpf;Fk; 
   tha;ehb tha;g;gr; nray;” 
                                                     -   jpUf;Fws; 
Neha; ehly;  -  Nehia gw;wpawpjy; 
Neha; Kjdhly;  -  Neha;f;fhd fhuzq;fis mwpjy; 
 
 rpj;jh;fs; clk;G> Neha;> Neha;f; fhuzk; Mfpatw;iwg; gw;wpawpe;J 
Nehia fzpj;Js;sdh;. Neha;f;fhd FwpFzq;fisf; nfhz;L 
fzpj;Js;sdh;.  vz;tifj; Njh;Tfs; %yk; Nehia ehk; vspjhff; 
fzpf;fyhk;. 
 
vz;tifj;Njh;T ghh;f;f Ntz;baJ moy;fPy;thAtpy; fz;lJ
1. eh epwk;> jd;ik kh gbe;Js;sJ 
2. epwk; Kf;Fw;w epw khWghL rpyhpy; %l;Lfspy; rpte;j 
epwk; 
3. nkhop Xyp> jd;ik khw;wkpy;iy 
4. tpop epwk;> nray; khw;wkpy;iy 
5. kyk; Kf;Fw;w epw
khWghL jd;ik 
fUg;G thjk; 
kyr;rpf;fy; 
6.%j;jpuk; 
  ePh;f;Fwp 
epwk;> kzk;>vil
vQ;ry; 
khw;wkpy;iy 
  nea;f;Fwp  Mopnad gutpaJ  
Kj;njhj;J epd;wJ.  
7. ehb Kf;Fw;w epiy thj gpj;j ehb 
8. ];ghprk; ntg;gk; my;yJ Fsph;r;rp rpyhpy; %l;Lfspy; 
ntg;gk; 
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kyk;: 
 tspapd; ,aw;ifg; gz;ghd kyk; Kjypa 14 tpiuTfis 
ntspg;gLj;jy; njhopypy;> ghjpg;G Vw;gl;L kyr;rpf;fy; Vw;gLfpd;wJ. ,U 
Koq;fhy;fspy; typ ,Ug;gjhy; moy; fPy;thA Nehahspfs; 
kyr;rpf;fyhy; jtpf;fpd;wdH. 
 ‘kykij alf;fpdhNy 
  kye;jid thA js;Sk; 
 ryNjhl Koq;fh ypd;fPo;j; 
  jd;ikaha; NehTz; lhFk; 
 jiytyp kpfTz;lhFk; 
  rj;jkh kghd thA 
 ngykJ FiwAk; te;J 
  ngUj;jpLk; tpahjp jhNd” 
kykij mlf;fpdhy; ryNjhlk;> Koq;fhypd; fPo;j; jd;ikahd Neha; 
Mfpa ,it cz;lhFk;. 
ehb: 
  clypd; capH jhpj;jpUg;gjw;Ff; fhuzkhd rf;jp vJNth> mJNt 
jhJ my;yJ ehb vdg;gLk;. 
  
‘gpj;jj;jpy; thjkhfpy; gplhpAq;fhYq;ifAq; 
  Fj;jJ NghNyahFq; FWjp nka;gJWk; gpd;Nd 
  mj;jpahAyUNkdpahf KQ;Ruj;jhy; Nehthk; 
  Gj;jpAkbAkpe;jj; nghWikNgha;f; NfhgkhNk.” 
 
 ‘thjj;jpy; Nrj;Jkkhfpy; typNahL tPf;f Kz;lhk;” 
- mfj;jpah; ehb 
‘jpUj;jkhk; thjj; NjhNl jPq;nfhL gpj;jk; Nrhpw; 
 nghUj;Jfs; NjhWk; nehe;J NghjNu gpbf;Fk;” 
- Fzthflk; Nehapd; rhuk; 
35 
 
‘fhzg;gh thj kPwpy; fhy;iffs; nghUj;jp NehFNk” 
- fhtpaehb. 
 ‘mwpe;Jghh; thjNk jdpj;jhdhy; 
rhpe;jplNt fhy; Klf;Fk;” 
- mfj;jpah; ,uj;jpdr; RUf;fk; 
 ‘taq;fpLk; thjkpuz;L 
 Nrj;Jknkhd;nwhLkhfpy; 
 caq;fpLq; iffhy; nehe;J” 
       - Fwpailahsehb  
VO cly; jhJf;fspd; Ma;T: 
cly;jhJ njhopy; 
moy; fPy;thAtpy; 
,Ug;gJ 
rhuk; 
cliyAk;> kdijAk; Cf;fKwr; 
nra;tJ 
cly; Nrhh;T 
nre;ePH 
mwpT> td;ik> xsp> xyp> epiyf;fr; 
nra;tJ 
kdr;Nrhh;T 
Cd; 
clypd; cUtj;ij njhopw;fpzq;f 
mikj;jy;> vd;ig tsHj;jy;. 
rpyhpy; Ngrp#k;gy; 
nfhOg;G 
cWg;Gfs; jj;jk; nraiy fbdkpd;wp 
,aq;f cjtp nra;tJ. 
if fhy; Kl;L ePl;b 
klf;f rpukk; 
vYk;G cliy xOq;Fgl epWj;jp itj;jy; Koq;fhy; %l;by; typ
%is 
vd;Gf;Fs; epiwe;J td;ik> nkd;ik 
jUtJ 
fhy;%l;Lfspy; typ 
tPf;fk; 
ntz;zPH 
jdidnahj;j cUtg; ngUf;fpw;F 
Kjyha; epw;gJ 
,ay;G 
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QhNde;jphpaq;fspd; Ma;T: 
nrtp Xypia mwpa nra;jy; ,ay;G 
nka; clypy; Cw;iw mwpjy; 
fhy;%l;by; 
tPf;fk; typ 
fz; Xspia ghHf;f nra;jy; ,ay;G 
ehf;F Ritia mwpa nra;jy; ,ay;G 
%f;F thrid Efu nra;jy; ,ay;G 
 
moy; fPy; thAtpy; fPy;fspy; cs;s ];ghprj;jpy; ntk;ik kw;Wk; typ 
fhzg;gLfpwJ. 
fd;Nke;jphpaq;fspd; Ma;T: 
tha; trdpf;if nra;Ak; ,ay;G
if ,LjYk;> Vw;wYk; nra;Ak; ,ay;G
fhy; elf;fr; nra;Ak; 
fhy;%l;Lfspy; typ elf;fr; 
rpukk; 
vUtha; kyj;ij fopf;Fk; kyr;rpf;fy;
fUtha; fU> Rf;fpyj;ijf; fopf;Fk; ,ay;G
 
moy; fPy;thA Nehapy; fkdk;> tprHf;fk;> ghjpg;gilfpwJ. 
kUj;Jtk; 
1. jd;dpiy jphpe;j Kf;Fw;wq;fisAk; jd;dpiyg;gLj;j 
Ntz;Lk;. 
2. cs;kUe;J kw;Wk; ntspkUe;J xw;wlk;> njhf;fzk;> Mrdk; 
Kiwfs; toq;f Ntz;Lk;. 
3. gj;jpak; 
4. gpzpaZfh jw;fhg;G Kiwfs; 
 
 
37 
 
jd;dpiy jphpe;j thj Fw;wj;ij jd;dpiyg;gLj;j Ntz;Lk;. 
‘tpNurdj;jhy; thje;jhOk;” 
 
 15 kpyp nts;is vz;nza; fhiy kl;Lk; ntWk; tapw;wpy; 
nfhLf;f Ntz;Lk;. 
kUe;J nfhLf;f Muk;gpf;Fk;Kd; Kjy; ehs; tpNurdj;jpw;F 
xUKiw kl;Lk; nfhLj;J kWehs; Kjy; Ma;Tf;F 
vLj;Jf;nfhs;sg;gl;lkUe;J nfhLf;f Ntz;Lk;. 
1. Nguuj;ijr; #uzk; - 1 fpuhk; ,UNtis fhiy kw;Wk; ,uT 
cztpw;F gpd; fha;e;J Mwpa ePhpy; fye;J mUe;j Ntz;Lk;. 
2. ej;ijr;#hp vz;nza; - ntspg;gpuNahfk; 
 
gpw kUe;Jfs;: 
cs; kUe;J: 
 
Nehapdhpd; cly; td;ik> taJ> fhyk; kw;Wk; kUe;jpd; tPhpak; 
Mfpatw;iw Muha;e;J kUj;jpd; msit jPHkhdpf;f Ntz;Lk;. 
 
 1. tq;f nre;J}uk;  - 65kp.fpuhk; 
    rpUq;fp gw;gk;  - 65 kp.fpuhk; mDghdk; - Njd; 
    gtsgw;gk;  - 65 kp.fpuhk; 
  
2. fhsNkfk ehuhaz nre;J}uk; - 65 kp.fpuhk; 
    gts gw;gk;      - 65 kp.fpuhk;   mDghdk; -Njd; 
    Kj;J gw;gk;      - 65 kp.fpuhk;    
  
3. G+uz re;jpNuhjak; - 65 kp.fpuhk; 
    Kj;J gw;gk;  - 65 kp.fpuhk; 
    rpUq;fp gw;gk;  - 65 kp.fpuhk; 
 
 4. matPu nre;J}uk; - 65 kp.fpuhk; 
  5. ,ypq;f nre;J}uk; - 65 kp.fpuhk; 
 6. MWKf nre;J}uk; - 65 kp.fpuhk; 
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ntspkUe;J:  
 
1. rpw;whKl;b ijyk; 
2. cSe;J ijyk; 
3. rptg;G Ff;fpy; ijyk; 
4. tplKl;b ijyk; 
5. rlhkhQ;rpy; ijyk; 
6. kad ijyk; 
7. thj Nfrhp ijyk; 
8. ty;yhiu nea; 
 
xw;wlk;: 
 thjklf;fp> Mkzf;F> gpukp> nehr;rp> thjehuhzad; Mfpa 
,iyfis nfhLf;fg;gl;l ntspkUe;J ijyj;ij Ko;fp neUg;gpy; 
thl;b my;yJ Mkzf;F vz;nzapy; tjf;fp %l;LfSf;F xw;wpl typ> 
tPf;fk; FiwAk;. 
gyd;fs;: 
1. fPy;fspy; FUjp Xl;lj;ij mjpfg;gLj;JfpwJ. 
2. typ Fiwfpd;wJ. 
gj;jpak; (Dietary Restrictions) 
,r;rh gj;jpaj;jpy; ePf;Fk; nghUs;fs;: 
 ‘fLF ew;wpyj; njz;nza; $o;g; ghz;lq;fs; fliy 
 tLtjhfpa njq;Fkh tUf;if ew;fhak; 
 kbtp yhj nts;Ss;sp nfhs; Gifapiy kJngz; 
 ,lW ghfNyh lfj;jp ePf;fplypr; rhgj;jpak;’ 
- rpj;j kUj;Jthq;f RUf;fk;. 
fLF> vs;nea;> fypahz g+rzpf;fha;> fs;> fliy> Njq;fha; > 
khq;fha;> gyh> fhak;> g+z;L> nfhs;> Gifapiy> ngz;fs; Nrh;f;if> 
ghfy;> mfj;jp ,itfis ,r;rh gj;jpaj;jpy; ePf;f Ntz;Lk;. 
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‘Gsp Jth; tpQ;Rk; fwpahy; g+hpf;Fk; thjk;” 
 
Mjyhy; Gspg;G> Jth;g;G RitAs;s czT tiffis ePf;f 
Ntz;Lk;. kw;Wk; nts;is rHf;fiu ePf;f Ntz;Lk;. 
‘nra;fO ePh;Nfhile; Njd; kpsF ey;nyz;nza; 
 jq;F ngUq;fhae; jOjhio - vq;nfq;Fk; 
 $l;L rpWKj;Jnea; Nfhjpy; cOe;jpitfs; 
 thl;L kdp yj;ij kjp ” 
- gjhh;j;j Fz rpe;jhkzp. 
 
Nrh;f;fj;jf;fd :   nrq;fOePh;> Nfh~;lk;> FwpQ;rpj;Njd;> kpsF>  
vs;nea;> ngUq;fhak;> jOjhioapiy> 
rpw;whkzf;F nea;> cSe;J  fj;jphp gpQ;R> 
KUq;ifg; gpQ;R> mtiug;gpQ;R> thiog; gpQ;R> 
Kisf;fPiu> nea;> ghy;> NkhH> kw;Wk; 
Kisfl;ba gapW tiffs; rpwe;jJ. 
 
fPy;thjk; gpzpePf;fTk; kw;Wk; tuhky; jLf;f Mrdq;fs; 
gj;khrdk;:  
,lJfhiy tyJ njhilapYk;> tyJ fhiy ,lJ njhil kPJk; 
khw;wpg; NghlTk;. fhy; %l;Lfs; ,uz;Lk; jiuiaj; njhl Ntz;Lk.; 
Fjpfhy;fs; ,uz;Lk; tapw;wpd; mbg;ghfj;ijj; njhLk;gbahf 
mikf;fTk;. KJF vYk;ig Neuhf epkph;j;jpf; fk;gPukhf cl;fhu 
Ntz;Lk;. ,uz;L iffisAk; rpd; Kj;jpiuAld; itj;Jf; fz; 
ghh;itia %f;fpd; Edpapy; nrYj;jTk;. 
gyd;fs;; 
 mbtapw;Wg; gFjpf;F ,uj;j Xl;lk; mjpfkhFk;. Koq;fhy; 
%l;Lfspd; ,ilntsp mjpfhpf;fr; nra;J fPy;thj Neha;ia jPHf;Fk;. 
jtk;> jpahdk;> kd xUikg;ghl;Lf;F rpwe;j Mrdk;. cly; mtatq;fs; 
vy;yhk; tpiwg;ghf ,Uf;fhky;> vspjpy; nraYf;F ,zq;Fk;. 
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NfhKfhrdk;: 
 Kjypy; fhy;fis ePl;b Neuhf mkh;e;J gpd; tyf;fhiy klf;fp 
,lJ gpl;lj;jpw;F fPo; tuj;jf;fjha; mikj;J mjd; gpd; ,lf;fhiy 
tyJ fhypd; Nkyhf nfhz;L te;J klf;fp tyJ gf;fk; 
,Uf;fj;jf;fjha; itf;f Ntz;Lk;. ,U Koq;fhy; %l;LfSk; 
xd;wd;Nky; xd;W ,Uf;f Ntz;Lk;. KJF vYk;ig Neuhf epkph;;j;jp 
mkh;e;J> tyJ ifia Nkyhf cah;j;jp gpd;GwkhfTk; nfhzh;e;J> ,lJ 
ifia fPohfTk; gpd;GwkhfTk; nfhzh;e;J  ,U iftpuy;fisAk; 
Nfhh;f;f Ntz;Lk;. 
gyd;fs;: 
 ,jdhy; fPy;thjk; jPUk;. Koq;fhy; nghUj;Jfs;> Koq;if> Njhs; 
nghUj;Jfs;> KJFj;jz;L> ,Lg;g vYk;G ,it gyg;gLk;. EiuaPuYf;F 
ed;F fhw;W nry;Yk;. 
gtd Kj;jhrdk;: 
 Kjypy; fhy;fis ePl;b Nky; Nehf;fp gLf;f Ntz;Lk; gpd; ,U 
fhy;fisAk; ed;whf klf;fp iffspdhy; neQ;rpw;F mUNf nkJthf 
nfhz;L te;J %r;rpapid cs;Sf;F ,Oj;J rPuhf Rthrpf;f Ntz;Lk;. 
%r;rpapid cs; ,Of;Fk; NghJ iffis fhy;fspd; Nky; jsHj;jp 
gpbf;f Ntz;Lk;. 
gyd;fs;: 
 tapw;wpypUf;Fk; $Ljyhd thA ntspNaWk;> %l;Lfspy; 
jq;fpapUf;Fk; gpuhzrf;jp jilapd;wp nray;glr;nra;J moy; fPy; 
thAit jPHf;Fk;. 
tr;rpuhrdk; : 
 ,U Koq;fhy;fisAk; klf;fp mjd; Nky; mkh;e;J ,U 
iffisAk; Koq;fhy;%l;bd; kPJ itj;J cl;fhuNtz;Lk; 
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gyd;fs; : 
  %l;Lfspy; fhZk; moy; fPy; thA 
cl;fl;lhrdk; : 
 Kjypy; Neuhf epd;W Koq;fhy;fis nkJthf klf;fp 
ehw;fhypapd; kPJ cl;fhUtJ Nghy; ,Uf;f Ntz;Lk;  
gyd;fs; : 
njhil rJ %yp NgrpfSf;F td;ik mspf;fpd;wJ. 
njhf;fzk; : 
 ,JNt kh;j;jdk; vdg;gLk; tspahy; cz;lhff; $ba Neha;fs; 
vy;yhtw;iwAk; ePf;Ftjw;F ,J gad;gLk;> 
‘njhf;fzj;jp dhypuj;je; Njhy; C zpitfl;F 
kpf;F rTf;fpaQ;r kPuDk;Ngh - nka;f;fjpf 
Gl;bAwf;fk; GzHr;rp apitfjpf;Fk; 
gl;l miyr;ryWk; ghH.” 
     - nghUl; gz;G E}y; 
gpbj;jy;: 
gpbj;jyp aq;Fk; ikjpap De;jFk; gpe;jhNj - vz;nz 
ALj;jJ nra;apw; wrtsp A+Dl Ye;jhNj 
Ntw;wJ nra;apDQ; #rpif ghhpir tpl;NlhLk; Gyp 
Nghw;wJ that kw;WJ Nkdypg; nghl;NlhLk; 
       - Njud; jU 
moy; fPo; thAtpy; - gpbj;jy; tif njhf;fzk; gad;gLfpwJ. 
 
Nehapd;wp tho topKiwfs;: 
ehs; xOf;fk;: 
1. fha;e;J Mwpd nte;ePH> ePH fye;j Nghu Nghd;wit 
ehnshd;Wf;F 3 ypl;lH Fiwahky; mUe;j Ntz;Lk;. 
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2. fha;fwp> goq;fs;> Kisfl;ba jhdpaq;fs; Mfpatw;iw 
mjpfkhf cztpy; NrHj;J nfhs;s Ntz;Lk;. 
3. fpoq;F tiffs;> nkhr;ir> nts;isr;ruf;fiu> Gspg;Grit 
kpFe;j czTfis jtpHf;f Ntz;Lk;. 
4. gfy; cwf;fk; nfhs;isf; $lhJ. 
5. clw; gapw;rpfis nra;J cly; vilia rpuhf;f Ntz;Lk;. 
 fhy xOf;fk;: 
1. FspHfhw;wpy; (kpd;tprpwp) <Lglf; $lhJ 
2. thuk; xU Kiw vz;nza; Fspay; nra;a Ntz;Lk; 
3. 45 ehl;fSf;F xU Kiw erpak; nra;J nfhs;s Ntz;Lk; 
4. ehd;F khjq;fSf;F xU Kiw Ngjp kUe;J cl;nfhs;s 
Ntz;Lk; 
5. 6 khjq;fSf;F xU Kiw tkd kUe;J cl;nfhs;s Ntz;Lk;. 
Recent studies: 
 Nutritional Supplements 
 Diet to be taken: 
1. ASU (Avocado-soybean unsaponifiable) relieve OA pain and 
stimulate cartilage repair. 
2. Fish Oil 
3. Green tea 
4. Ginger has painkilling and anti-inflammatory agents 
5. Turmeric 
6. Wild yam 
Diet to be avoided: 
1. Eliminate nightshades – potatoes and tomatoes,  
2. Alkaline diet – Sugar, coffee, nuts and citrus fruits. 
- www.emedicine.com  
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 MODERN ASPECT 
 
 Osteoarthritis is the most common joint disorder, with knee involvement 
a major cause of disability in the community. It shows a strong association with 
ageing and is a major cause of pain and disability in the elderly. 
 
ANATOMY OF KNEE JOINT 
 
 Knee joint is a hinge joint formed by the condyles of the femur, the 
condyles of the tibia and the posterior surface of the patella.  The anterior part 
of the capsule consists of the tendon of the quadriceps femoris muscle which 
also supports the patella. 
Intracapsular structures include two cruciate ligaments which cross each 
other, extending from the inter condylar notch of the femur to the inter 
condylar eminence of the tibia.  They help to stabilize the joint. 
Semilunar cartilages or menisci are incomplete discs of white fibro 
cartilage lying on the top of the articular condyles of the tibia.  They are wedge 
shaped, being thicker at their outer edges.  They help to stabilize the joint by 
preventing lateral displacement of the bones. 
Bursae and pads of fat are numerous.  They prevent friction between a 
bone and a ligament or tendon and between the skin and the patella.  Synovial 
membrane covers the cruciate ligaments and the pads of fat. 
The menisci are not covered with synovial membrane because they are 
weight bearing. The most important strengthening ligaments are the medial and 
lateral collateral ligaments. 
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Integrity of the knee joint: 
Lateral motion and rotatory motion of the knee joint in extension is 
controlled by the capsule, collateral ligaments and cruciate ligaments, in 
flexion, by the same structures minus the fibular collateral ligament. 
Forward gliding of the tibia on the femur is controlled by the anterior 
cruciate ligament and the quadriceps. 
Backward gliding of the tibia on the femur is controlled by the posterior 
cruciate ligament and the posterior capsule. 
Lateral gliding of the tibia on the femur is controlled by tibia, inter 
condylar spine and the femoral condyles with the aid of all the ligaments. 
Hyper extension is controlled by both the collateral ligaments, both 
cruciate ligaments, both menisci, the posterior aspect of the articular capsule, 
the oblique popliteal ligament and the architecture of the femoral condyles. 
Hyperflexion is controlled by both cruciate ligaments, both menisci, the 
femoral attachment of the posterior aspect of the capsule, the femoral 
attachment of both heads of gastrocnemius muscle and the bony, structure of 
the condyles of the femur and the tibia. 
The menisci cushion both hyper extension and hyper flexion.  The tibial 
collateral ligaments are closely related to the medial meniscus but there is no 
strong fibrous tissue attachment between them.  The tibial collateral ligament 
glides forward and backward in extension and flexion. 
 
ARTICULAR CARTILAGE 
The ends of the bones in a synovial joint are covered with a layer of 
articular cartilage.  This is an avascular tissue that consists of cartilage cells 
(chondrocytes) embedded in a thick matrix of proteoglycans, water, type II 
collagen and smaller amount of other proteins.  
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Although there is no cell division in normal cartilage, chondrocytes are 
metabolically active cells that are responsible for synthesis and turnover of 
cartilage matrix throughout life.  The matrix consists of a meshwork of type II 
collagen fibrils that run through a hydrated gel of proteoglycan molecules, the 
most important of which is aggrecan. 
Aggrecan consists of a core protein, to which several 
glycosaminoglycan (GAG) side chains are attached GAGs consist of long  
chains of disaccharide repeats in which the disaccharide consists of one 
ordinary sugar linked to an amino sugar. 
The most important GAGs, are chondroitin sulphate and keratan 
sulphate.  Cartilage also contains hyaluronan, a long GAG consists of multiple 
glucuronic acid and N-acetyl galactosamine disaccharide repeats.   
Hyaluronan binds several aggrecan molecules by interacting with a 
domain at the N-terminus of the core protein along with a small glycoprotein 
called link protein that acts to stabilise the complex.  Large complexes of 
aggrecan and hyaluronan can form in cartilage with a total molecular weight in 
excess of 100 million. 
The expansive force of the negatively charged and hydrated aggrecan 
combined with the restrictive force of the collagen meshwork, gives articular 
cartilage excellent shock- absorbing properties. 
With ageing, the amount of chondroitin sulphate decreases whereas that 
of keratin sulphate increases.  The end result is reduction in water content and 
impairment of cartilage’s shock-absorbing properties.  Age related changes in 
cartilage differ from those found in OA, where there is abnormal chondrocyte 
division, loss of proteoglycan from matrix and an increase in water content. 
Cartilage matrix is constantly being turned over and in health a perfect 
balance is maintained between synthesis and degradation of matrix 
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components.  Matrix degradation is thought to be mediated by proteolytic 
enzymes such as aggrecanase and matrix metallo proteinases that degrade the 
core protein of aggrecan and other matrix proteins.  Glycosidases degrade the 
GAG side-chains. 
Group of diseases, termed mucopolysaccharidoses, in which genetic 
mutations in glycosidases occur, resulting in excessive accumulation of GAGs 
in various tissues. 
Pro-inflammatory cytokines such as interleukin (IL-1) and tumour 
necrosis factor (TNF) which are involved in joint inflammation are known to 
upregulate production of aggrecanase, metalloproteinases and other enzymes 
that cause matrix degradation, thereby promoting cartilage damage. 
This is offset by up regulation of inhibitors of proteinases in cartilage, 
called tissue inhibitors of metalloproteinases (TIMP) which oppose the effects 
of degrading enzymes and protect against matrix degradation. 
Zones of articular cartilage 
1. Superficial layer (tangential zone) 
Makes up 10% of cartilage 
Two Sub Zones 
a. Fibrilar sheet – most superficial layer 
It is a clear film consisting of a sheet of small fibrils with little 
polysaccharide and no cells. 
b. Cellular layer with flattened chondrocytes: 
  Flat chondrocytes and collagen fibers are arranged                           
tangentially  to the articular surface. 
 Superficial layer is the thinnest layer, with the highest content of 
collagen and the lowest concentration of  proteoglycans. 
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Collagen (type IX) is arranged at right angles to adjacent bundles and 
parallel to the articular surface. 
Subsequently has greatest ability to resist shear stresses and serves as a 
gliding surface for joint. 
May also function to limit passage  of large molecules between synovial 
fluid and cartilage. 
Superficial zone is the first to show changes of osteoarthritis. 
2.Transitional layer 
This zone involves transition between the shearing forces of superficial 
layer to compression forces in the cartilage layers. 
 composed almost entirely of proteoglycans 
 Spherical chondrycytes 
 Less strongly bound. 
3.Deep radial layer 
 Largest part of the articular cartilage 
 It distributes loads and resists compression 
 Collagen fibres and chondrocytes are perpendicular to subchondral plate 
4.Calcified cartilage layer 
 Contains the tidemark layer 
 Tidemark is basophilic line which stradles the boundary between 
calcified and uncalcified cartilage. 
 Separate hyaline cartilage from subchondral bone. 
 Type X collagen is present mainly in the calcified cartilage layer and in 
hypertrophic zone of the growth plate. 
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OSTEOARTHRITIS 
 
Synonyms: 
 Osteoarthrosis; Degenerative arthritis; hypertrophic arthritis; post-
traumatic arthritis Chondromalacic Arthritis, Arthrits Deformans 
Definition: 
 Osteoarthrosis is a chronic joint disorder in which there is a progressive 
softening and disintegration of articular cartilage accompanied by new growth 
of cartilage and bone at joint margin (Osteophytes) and capsular fibrosis. These 
changes result from a variety of abnormalities that predispose to mechanical 
failure of the hyaline articular cartilage. 
 Clinically it is defined by recurring episodes of pain, synovitis with 
effusion, stiffness and progressive limitation of motion and radiologically by 
narrowing of the joint interval, increased density and thickening of the 
subchondral bone, subchondral cysts and marginal bony excrescences. 
Principle site of Osteoarthritis: 
 Osteoarthritis preferentially targets only certain small and large joints, 
the knee and hip are the principle sites of significant disability. Knee 
Osteoarthritis is more prevalent than hip osteoarthritis. 
Aetiology: 
 It is caused by wear and tear. If a joint were never put under stress, it 
would never become Osteoarthritic. Hence the relatively lightly stressed joints 
of the upper limb are, in general less prone to osteoarthritis than the heavily 
stressed joints of the lower limb. 
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Predisposing Factors: 
1.Age: 
 Osteoarthritis increase with frequency of age. The process appears to 
begin in the second decade of life, but degenerative changes are apparent by 55 
to 65 years of age. Approximately 85% have roentgenologic evidence to a 
variable degree of the disease. 
2. Sex: 
 Under the age of 55 years, the joint distribution of osteoarthritis in men 
and women is similar, in older individuals hip osteoarthritis common is men, 
while osteoarthritis of interphalangeal joints and thumb base is more common 
in women. 
3. Hereditary: 
 The relation of hereditary to osteoarthritis is less ambiguous. Thus the 
mother and sister of a woman with distal interphalangeal joint osteoarthritis 
(Heberden’s nodules) are respectively, twice and thrice as likely to exhibit 
osteoarthritis in these joints as the mother and sister of an unaffected woman. 
4. Race: 
 Knee osteoarthritis is prevalent in all racial groups but hip, hand and 
generalized osteoarthritis are only prevalent in Caucasians. 
5. Major trauma and repetitive joint use: 
Major acute knee injuries including cruciate ligament and meniscal tears 
are common causes of knee osteoarthritis. 
Osteoarthritis changes have been reperted in up to 89% of people after 
meniscectomy. 
Although damage to the articular cartilage may occur at the time of 
injury or subsequently, with use of affected joint ,even normal cartilage will 
50 
 
degenerate if it is unstable. A person with a trimalleolar fracture will almost 
certainly develop ankle osteoarthritis. 
6. Obesity: 
 In obese persons the disease often assumes the generalized pattern more 
typical in women. For those in the highest quinfile for body mass index at 
baseline examination, the relative risk for developing knee osteoarthritis in the 
ensuing 36 years was 1.5 for men and 2.1 for women. For severe knee 
Osteoarthritis the relative risk ratio to 1.9 for men and 3.2 for women. A weight 
loss of 5 kg was found to be associated with 50% reduction in the odds of 
developing symptomatic knee osteoarthritis. 
7. Occupation: 
 People associated with high rates of osteoarthritis  include farmer hip 
osteoarthritis), jack hammer operaters and base ball pitchers (elbow), miner 
(knee and spine osteoarthritis), cotton mill worker (hand osteoarthritis) and 
ballet dancers (ankle osteoarthritis). 
8. Sports activities: 
 Osteoarthritis is associated with a variety of sports activities including 
running (hip osteoarthritis) and soccer playing (knee and hip osteoarthritis). 
 
9. Developmental Deformities: 
 Anatomical abnormalities of the knee and hip that are present at birth or 
that develop during childhood may result in accelerated or premature 
osteoarthritis. 
 These include genu varum, genu valgum, Perthe’s disease in later life,  
congenital hip subluxation, slipped capital femoral epiphysis and acetabular 
dysplasia. 
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10. Sex Hormones: 
 Osteoarthritis occurs more frequently in women after the age of 50 than 
in men of same age. Epidemiologic studies of women who take oestrogen 
replacement therapy report that these woman are less likely to have 
osteoarthritis than women not taking oestrogen. 
11. Nutritional deficiencies: 
 Low vitamin D and Vitamin C intake are associated with increased risk 
of knee osteoarthritis progression. 
12. Metabolic and Endocrine disorders: 
 These are associated with secondary forms of osteoarthritis. People with 
diabetes may be prone to osteoarthritis. Others include hypothyroidism, 
acromegaly and hyperparathyroidism. 
13. Inflammatory Diseases: 
 Rheumatoid arthritis and septic arthritis may progress to osteoarthritis. 
14. Inadequate blood supply: 
 Avascular necrosis of the bones. 
15. Genetic Factors: 
 Point mutation in DNA coding for articular cartilage collagen have been 
identified in families with chondrodysplasia and polyarticular secondary 
osteoarthritis. 
PATHOLOGY: 
The cardinal features are 
 i) Progressive cartilage destruction 
 ii) Subarticular cyst and microfractures formation 
 iii) Sclerosis of the surrounding bone 
 iv) Osteophytes or spur formation 
 v) Joint mice or Loose bodies formation. 
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 vi) Fibrosis of the capsule 
 The weight bearing joints such as hips, knee and vertebrae are most 
commonly involved but interphalangeal joints of fingers may also be affected. 
 The pathologic changes occur in the articular cartilages ,adjacent bones 
and synovium 
I . Changes in the Articular Cartilage: 
 The regressive changes are most marked in the weight bearing regions 
of articular cartilages. ( Medial) 
 There is enzymatic degradation of the major structural components, 
aggrecan and collagen. So there is loss of cartilaginous matrix 
(proteoglycans) resulting in progressive loss of normal metachromasia. 
 Focal loss of chondrocytes and at other places, proliferation of 
chondrocytes forming clusters eventually leading to fissuring of the 
cartilage surface (Fibrillation), development of deep vertical clefts, 
localised chondrocyte death and decrease in cartilage thickness. 
 Radiologically this progressive loss of cartilage is apparent as ‘narrowed 
joint space’. 
 Molecular mechanism of damage to cartilage in osteoarthritis appears to 
be the breakdown of collagen type II probably by IL-1, TNF and nitric 
oxide. 
 Changes in OA cartilage encourage deposition of calcium 
pyrophosphate and apatite crystals. 
II Changes in the bone:  
 The bone response immediately below the compromised cartilage 
increases its trabecular thickness. In some cases this reflects heated 
trabecular microfractures. 
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 Holes (cysts) often develop, possibly due to the result of small areas of 
osteonecrosis caused by the increased pressure in bone as the cartilage 
fails in its load – transmitting function. 
 At the margins of the joint there is production of new fibrocartilage 
which then undergoes endochondral ossification to form osteophyte. 
 With severe cartilage loss there may be attrition of bone as the two 
unprotected bone ends wear on each other leading to ablation of 
trabeculae resulting in smooth, shiny surface- eburnation often with 
deep linear grooves. 
 Bone remodeling and cartilage thinning slowly alter the shape of OA 
joint, increasing its surface. 
 Loosened and fragmented detached osteophytes may form free “joint 
mice or loose bodies” 
 The muscles that act over the joint commonly show non-specific type-
II fibre atrophy. 
III  Changes in the synovium:  
 The synovium undergoes variable degrees of hyperplasia. 
 In advanced cases there is low grade chronic synovitis and villous 
hypertrophy. 
 There may be some amount of synovium effusion associated with 
chronic synovitis. 
PATHOGENESIS  
Transformation of Normal cartilage to Ageing cartilage:  
 Several structural and biochemical changes involving the collagenous 
components of the matrix occur during aging. These changes alter biochemical 
properties of the cartilage that are essential for the distribution of forces in the 
weight bearing zone. 
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 Glycosaminoglycans are modified qualitatively, they become shorter as 
the cartilage ages. The concentration of type 6 keratan suphate increases during 
ageing, to the detriment of type 4 karatan sulphate. 
 These quantitative and qualitative changes in proteoglycan reduce the 
capacity of the molecules to retain water. Thus aging cartilage contain less 
water which alter the biochemical properties of the cartilage. Fissures that 
develop in cartilage during ageing are mainly due to stress fractures of the 
collagen network. 
Classification 
 Osteoarthritis is grossly classified into two types. They are 
 1. Primary Osteoarthritis   2. Secondary Osteoarthritis 
I.Primary Osteoarthritis 
 No previous Pathology 
 It is due to wear and tear changes occurring in old age in which weight 
bearing joints like hips and knees are commonly affected. 
II.Secondary Osteoarthritis 
 Secondary to some previous Pathology. 
 It is due to an abnormal wear and tear in a joint caused by mechanical 
incongruity of the articular surfaces. 
This incongruity may be the result of a preceding fracture involving the 
articular surface or partial destruction or deformity ue to a previous disease. 
Causes: 
1. Malunion of fractures involving the articular surface of tibia, femur or 
patella. 
2. Loose bodies in the Joint 
3. Malalignment of the bones due to deformity like genu valgum. 
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a) Group I    Crystal deposition Type 
  - Hyperparathyroidism 
  - Haemochromatosis 
  - Wilson’s disease 
  - Gout 
  - Oxalosis 
  - Calcium pyrophosphate deposition disease 
  - Basic calcium phosphate deposition disease 
b) Group II   Necrosis or abnormality in the subchondral bone 
  - Post traumatic Osteoarthritis 
  - Aseptic necrosis 
  - Legg- perthes’ disease 
  - Paget’s disease. 
  - Steroid arthropathy 
c) Group III Abnormal joint laxity 
  - Echlers Danlos syndrome 
  - Osteogenesis imperfecta 
  - Marfan’s syndrome 
d) Group IV Abnormal cartilage growth or function 
  - Acromegaly 
  - Achrondroplasia 
  - Spondylo epiphyseal dysplasias 
  - Multiple epiphyseal dysplasias 
  - Congenital hip dysplasia 
  - Mucopolysaccharidoses 
  - Ochronosis 
  - Diabetes Mellitus 
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e)Group V Synovial destructive of cartilage and bone  
  - Post inflammatory Osteoarthritis 
  - Post infectious Osteoarthritis 
  - Hemophilic arthropathy. 
Cause of young onset osteoarthritis ie. below 45 years 
Mono-arthritis  
 Previous trauma and localised instability 
Pauci-articular or poly articular 
 Prior joint disease (Juvenile idiopathic arthritis) 
 Metabolic or Endocrine diseases 
 Epiphyseal dysplasia 
 Late avascular necrosis 
 Neuropathic joints 
 Endemic Osteoarthritis 
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Clinical Features: 
Pain   
 Patients over age 45(often over  age 60) 
 Insidious onset over months or years  
 Variable or intermittent over time  
 Mainly related to movement and weight bearing, relieved by rest  
 Only brief (less than 15 minutes) morning stiffness and brief (less than  
1 minute) gelling after rest   
    Usualy only one or few joints painful  
Causes of Pain:  
 In some patients it may be due to stretching of nerve ending in the 
periosteum  
 In others it may arise from micro fractures in subchondral bone or from 
medullary hypertension caused by distortion of blood flow by thickened 
subchondral trabeculae. 
 Joint instability leading to stretching of the joint capsule, and muscle 
spasm also source of pain. 
 In some patients, joint pain may be due to synovitis. 
 In advanced osteoarthritis, histological evidence of synovial 
inflammation may be as marked as that in rheumatoid arthritis. 
Synovitis in osteoarthritis may to due to phagocytosis of shards of  
cartilage of soluble matrix macromolecules or to crystals of calcium 
pyrophosphate.] 
 In other cases, immune complexes, containing antigens derived from 
cartilage matrix may be sequested in collagenous tissue of the joint 
leading to low grade chronic synovitis. 
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Clinical Signs: 
 Restricted movement due to capsular thickening and blocking by 
osteophyte. 
 Swelling - Intermittent due to effusion 
 Continuous due to capsular thickening 
 Bony swelling due to osteophytes around joint margin. 
 Deformity due to capsular contracture without joint instability 
 Crepitation, palpable, sometimes audible coarse crepitus due to rough 
articular surfaces. 
 Temderness periarticular or joint line 
 Muscle weakness or wasting 
 Mild synovitis due to effusion (increased warmth) 
OA at specific joint sites: 
Erosive OA: 
 Distal and /or proximal interphalangeal joints of the hands are most 
prominently affected.  Erosive OA tends to be more destructive than typical 
nodal OA. 
Generalized OA: 
1. Generalized OA is characterized by involvement of three or more joints 
or groups of joints (distal interphalangeal and proximal interphalangeal 
joints are counted as one group each).  Heberden’s and Bouchard’s 
nodes are prominent.  Symptoms may be episodic, with “flare-ups” of 
inflammation marked by soft tissue swelling, redness, and warmth. 
2. Marked female preponderance 
3. Peak onset in middle age 
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Thumb Base: 
1. The second most frequent area of involvement of OA is the thumb base.  
Swelling, tenderness, and crepitus on movement of the joint are typical.  
Osteophytes may lead to a “squared” appearance of the thumb base. 
2. Good functional outcome for hands and strong genetic predisposition 
3. Predisposition to OA at other joints, especially knees. 
The Hip: 
 Congenital or developmental defects (e.g., acetabular dysplasia, slipped 
capital epiphysis) may be implicated in as many as 80 percent of cases of hip 
OA. 
The Knee: 
 OA of the knee may involve the medial or lateral femorotibial 
compartment and/or the patellofemoral compartment.  OA on the medial 
compartment may result in a varus, (bow-leg) deformity; in the lateral 
compartment it may produce a valgus (knock-knee) deformity.   
Local examination findings  
1. A jerky, asymmetric ‘antalgic gait’ – less time weight bearing on the 
painful side. 
2. A positive “shrug” sign (pain when the patella is compressed manually 
against the femur during quadriceps contraction) may be a sign of 
patellofemoral OA. 
3. Joint line and / or periarticular tenderness (secondary anserine 
bursitis and medial ligament enthesopathy are common, giving 
tenderness of the upper medial tibia). 
4. Weakness and wasting of the quadriceps muscle 
5. Restricted flexion / extension with coarse crepitus 
6. Bony swelling around joint line. 
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 Calcium pyrophosphate dehydrate (CPPD) crystal deposition in 
association with OA is most common at the knee. 
The Spine: 
 Degenerative disease of the spine can involve the apophyseal joint, 
intervertebral discs, and/or paraspinous ligaments.  Symptoms of spinal OA 
include localized pain and stiffness.  Nerve root compression by an osteophyte 
blocking a neural foramen, prolapse of a degenerated disc, or subluxation of an 
apophyseal joint may cause radicular pain and motor weakness. 
Laboratory and Radiographic Findings: 
 No laboratory studies are diagnostic for osteoarthritis, but specific 
laboratory testing may help in identifying one of the underlying causes 
of secondary osteoarthritis. 
 Analysis of synovial fluid reveals mild leucocytosis (<2000 WBC/ 
microlitre) with a predominance of mononuclear cells.Analysis of 
synovial fluid is helpful in diagnosing various types of arthritis by 
changes in its viscosity cell content and biochemical features. 
 
APPROPRIATE COMPOSITION OF SYNOVIAL FLUID 
 Proteins         -  2.8 gm/100gm 
 Albumin        - 1.9 gm/100gm 
 Globulin       - 0.9gm/100gm 
 Fibrinogen  -  Nil 
 Aminoacid      -  Nil 
 Total lipids      -  Nil 
 Fatty acid        -  Nil 
 Cholesterol       -  Nil  
 Urea        -  Nil 
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 Creatinine     -  Nil    
 Glucose     -  65-90mg/100gm        
 Sodium    -   310mg/100gm        
 Potassium    -  16mg/100gm       
 Calcium    - 10mg/100gm 
 Inorganic Phosphorus - Nil 
 P.H            - 7.29-7.49 
 Water            -  96.6gm/100gm        
 
 The diagnosis of OA is usually based on clinical and radiographic 
features. In the early stages, the radiograph may be normal, but joint 
space narrowing becomes evident as articular cartilage is lost. Other 
characteristic radiographic findings are. 
1. Asymmetric loss of cartilage (narrowing of the joint space). 
2. Sclerosis of the subchondral bone under the area of cartilage 
loss 
3. Cysts close to articular surface and  
4. Osteophytes at the margins of the joint. 
Radiological Classification of OA knee (Ahlbach) AP weight bearing and 
lateral Views. 
Type I  - Joint space narrowing. 
Type II - Total loss of joint space 
Type III - < 5 mm tibial erosion but posterior part of the plateau  
intact. 
Type IV - > 5 mm tibial and posterior plateau erosion. 
Type V - Subluxation 
Note : Grades IV and V : Total knee replacement is the line of treatment. 
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¾ Radio isotope bone scans shows discrete increased uptake in OA joints 
due to bone remodeling.  
¾ Arthroscopy may show cartilage damage long before X-ray changes 
appear. 
Complications: 
1. Bone Death (Osteonecrosis) 
2. Stress fractures (Hairline  crack in the bone that develop gradually in 
response to repeated injury or stress) 
3. Bleeding inside joints. 
4. Infection in the joints 
5. Rupture of the tendons and ligaments in the joints 
6. Capsular herniation:  OA of the knee is sometimes associated with a 
marked effusion and herniation of the posterior capsule (Baker’s cyst). 
7. Loosebodies:  Cartilage and bone fragments may give rise to loose 
bodies, resulting in episodes of locking. 
8. Rotator cuff dysfunction:  OA of the acromio clavicular joint may 
cause rotator cuff impingement, tendonitis or cuff puncture. 
9. Spinal stenosis:  Long standing hypertrophic OA of the lumbar 
apophyseal joints may rise to acquired spinal stenosis. 
10. Spondylolisthesis:  In patients over 60 years of age, destructive OA of 
the apophyseal joints may result in severe segmental instability and 
spondylolisthesis (degenerative spondylolisthesis) which almost always 
occurs at L4, L5. 
Clinical variants: 
1. Monoarticular and pauciarticular OA: 
 Underlying abnormality acetabular dysplasia, old Perthe’s disease or 
slipped epiphysis, a previous fracture or damage to ligments or menisci. 
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2. Polyarticular OA: 
 Pain, swelling and stiffness of the finger joints the first carpometocarpal 
and big toe metatarsophalangeal joints or the knees and lumbar facet joints may 
be affected. 
 Long standing cases, osteophytes and soft tissue swelling produce a 
characteristic knobbly appearance of the distal inter phalangeal joints 
(Heberden’s node) and less often the proximal interphalangeal joints 
(Bouchard’s nodes). 
3. Endemic OA: 
 OA occasionally occurs as endemic disorder affecting entire 
communities.  It may either due to some environmental factor peculiar to that 
region or to an underlying generalized dysplasia in a genetically isolated 
community. 
4. Neuropathic joint disease (Charcot’s disease): 
 The most destructive arthroplasty is that associated with lack of pain 
sensibility and position sense. 
 
DIFFERENTIAL DIAGNOSIS OF OA: 
1. Avascular necrosis: 
 Idiopathic necrosis causes joint pain and local effusion.  Early on the 
diagnosis is made by MRI.  Once bone destruction occurs the X-ray changes 
can be mistaken for those of OA;  The cardinal distinguishing features is that in 
osteonecrosis is the ‘point space’ (articular cartilage) is preserved in face of 
progressive bone collapse and deformity. 
2. Inflammatory Arthropathies: 
 RA, Ankylosing spondylitis and Reiter’s disease may start in one or two 
large joints.  X-rays show a predominantly atrophic or erosive arthritis. 
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3. Polyarthritis of the fingers: 
 Polyarthritis OA may be confused with other disorders which affect the 
finger joints.  ‘Nodal OA’ affects predominantly the distal joints, “Rheumatoid 
Arthritis” the proximal joints and “Psoriatic arthritis” is a purely destructive 
arthropathy and there are no inter phalangeal nodes.  Tophaceous gout may 
cause knobbly fingers, but the knobs are tophi, not osteophytes. 
Management: 
 The management of OA depend upon the joint involved, the stage of the 
disorder, the severity of the symptom, the age of the patient and his or her 
functional needs. 
Early Treatment: 
 There is as yet, no drug that can modify the effects of OA.  Treatment is 
therefore symptomatic.  The principles are 
i. Maintain movements and muscle strength. 
ii. Protect the joint from overload. 
iii. Relieve pain. 
iv. Modify daily activities. 
Conservative Treatment: 
1. Rest: The involved joints are rested to reduce compression and shear 
stresses and allow the synovial inflammation to subside. 
2. Range of motion:  The joint is moved through a full range of motion 
several times daily to prevent capsular contraction. 
3. Load reduction:  protecting the joint from excessive load may slow down 
the rate of cartilage loss.  Measures such as weight reduction for obese 
patients, wearing shock-absorbing shoes, avoiding activities like climbing 
stairs and using a walking stick will pay excellent dividends. 
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4. Traction: Traction is used slowing the acute inflammatory phase, 
particularly of a weight bearing joint.  To separate the joint surfaces and to 
stretch the contracted capsule until the inflammation subsides. 
5. Physical therapy:  Moist heat is followed by massage and range of motion 
exercises, both passive and active.  Painful Heberden’s nodes are aided by 
plain hot water soaks or paraffin applications. 
 Cryotherapy: It is used for the relief of pain, muscle spasm and 
oedema. The application of ice and cold packs may also be used to produce 
vasoconstriction and to block pain pathways in the treatment of acute traumatic 
and inflammatory swelling – Outline of orthopaedics – John Crawford 
Adams. 
6. Body mechanics:  Good body mechanics is aided by eliminating faulty 
posture, applying shoe supports, and performing graduated exercises of all 
joints. 
7. Orthopaedic appliances:  A removable plaster splint secures rest and 
permits daily physical therapy.  An ordinary elastic bandage applied around 
the affected joint restricts the extremes of motion while permitting a little 
use. 
8. X-ray therapy:  This is supposedly acts by reducing inflammation and 
minimizing scar tissue formation. 
 
Other Useful Approaches in the management of Osteo Arthritis 
 Simple changes around the home and daily activities causes dramatic 
improvement in the cure of  osteoarthritis.  They are 
a. Use of higher chair which require less effort to get in and get out should 
be considered. 
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b. To reduce the force acting across, the injured joint, the patient is advised 
to use a walking stick which acts as a third limb. 
c. Foot wear with hard soles and high heels should be avoided. 
d. Maintain ideal body weight 
e. General advice when standing. 
 Keep as upright as possible as this helps to put equal weight on both 
the legs. 
 Avoid sitting on a low or soft chair. 
 To avoid uneven and rough ground or surfaces while walking.                     
 
Exercises in the Management of OA of Hip and Knee: 
Aims: 
 To increase the range of movements. 
 To increase stability and shock absorption . 
 To prevent deformity. 
 To improve posture. 
 To reduce pain and stiffness. 
Rules: 
 Build up the exercises gradually. 
 Avoid rough ground while exercising. 
 To take warm baths before starting the exercises. 
 To perform the exercises 20 times each twice a day and later four 
times a day. 
Exercises Lying on the Back: 
1. Pelvic Tilt:  Tighten the thigh and buttock muscles, pushing the knees 
flat, hold for a count of five and relax. 
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2. Pelvic Lift:  Bend both the knees up, push on the feet and lift, hold for a 
count of five and relax. 
3. Leg Stretch:  Push one leg along the floor as though you are trying to 
make it longer than the other hold for a count of five and then repeat 
with the other leg. 
4. Alternate Leg Raising:  Keeping the knees straight, lift alternate legs 
six inches from the ground. 
Exercises lying on your side, with the Painful Hip up: 
1. Side leg raising:  Keep the top leg straight and lift it up as high as 
possible, hold for a count of five and relax. 
2. Knee and hip flexion:  Bend the hip and knee of the top leg forwards, 
and hold for a count of five.  Then straighten the leg and stretch back 
wards as far as it will go, hold for a count of five, then relax. 
Exercises in Sitting Posture: 
1. Knee together, feet apart:  Keep the knees together and move the feet 
apart, hold for a count of five then relax. 
2. Feet together, knees apart:  Keep the ankles together and move the 
knees apart, then relax. 
Exercises in Standing Posture: 
1. Standing leg Swing:  Hold into a table or chair with one hand, swing 
one leg forward and backward.  Try to get the backwards swing as wide 
as possible. 
2. Standing side leg swing:  Hold on to a chair with both hands.  Swing 
bad leg out as far as it will go and then in.  The outward swing is the 
hardest part and the leg should be allowed to fall back under muscular 
control. 
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MATERIALs AND METHODS 
 
 The study Azhal Keel vayu was carried out at Post Graduate Department 
of Sirappu Maruthvam, Government Siddha Medical College and Hospital, 
Palayamkottai under the observation and guidance of the author’s Head of the 
Department.Out of the 55 cases treated, 30 cases were selected in the In Patient 
and rest 25 in Out Patient ward. The cases were selected from the Post-graduate 
Out Patient Department (Sirappu-Maruthuvam) according to the signs and 
symptoms mentioned in the Siddha Maruthuvam text book. 
Selection of the cases: 
For this clinical study 30 patients suffering from Azhal Keel Vayu were 
selected and admitted in the In Patient ward of the Government Siddha Medical 
College and Hospital, Palayamkottai of both sexes & varying age groups. 
Aetiological Factors: 
 The seasonal variation and precipitating factors like emotional stress, 
trauma, occupation and change of climate were enquired.  The socio economic 
status, family history and other significant diseases already treated, were 
throughly studied. 
Selection Criteria: 
1. Affection of any one of the major joints with or without swelling. 
2. Morning stiffness. 
3. Restricted movements. 
4. Crepitation present in the affected joints. 
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In Siddha system the following aspect were taken into consideration. 
 1. Poriyal Therthal 
2. Pulanal Therthal 
3.  Vinathal 
4. Examination of Uyir Thathukal 
 5. Ennvagai thervugal 
6. Udal Kattugalin Nilaigal 
7. Neerkuri, Neikuri  
The following investigations were done in Modern medicine aspect. 
HAEMATOLOGICAL INVESTIGATIONS: 
 a) Total WBC count.    e)     Blood sugar. 
b) Differential WBC Count.   f)      Blood urea. 
c) Erythrocyte Sedimentation Rate.  g)     Serum cholesterol. 
d) Haemoglobin percentage. 
URINE ANALYSIS: 
a) Albumin. 
b) Sugar. 
c) Deposits. 
STOOLS EXAMINATIONS: 
a) Ova. 
 b) Cyst. 
 c) Occult blood. 
SPECIAL INVESTIGATIONS: 
X-ray of the affected joint. 
Selection of the drugs: 
 Selection of the drugs were made after the in-depth study of various 
Siddha literature. 
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The test drugs: 
Perarathai Chooranam (Internal) 
 Nathaichoori Ennai (External) 
PERARATHAI CHOORANAM:   
1gm twice a day morning and night after food with warm water. 
NATHAICHOORI ENNAI: 
 This oil was given only for external use on the affected joints. 
 The day before the study started, Vellai Ennai – 15ml was given at early 
morning as a mild purgative to all the patients. 
 The drugs selected for the study were subjected to the Pharmacological 
and Bio-chemical analysis. 
 Pharmacological analyses were done at the Department of 
Pharmacology, and Bio-chemical analysis was done at the Department of 
Biochemistry, Govt. Siddha Medical College, Palayamkottai. 
 All the patients admitted for the study were given uniformly regular 
hospital diet. 
 During discharge all the patients were advised to attend the Out Patient 
Department of Sirappu Maruthuvam Post-Graduate Govt. Siddha Medical 
College Hospital, Palayamkottai for the further follow-up. 
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RESULTS AND OBSERAVATIONS 
 
Results were observed with respect to the following criteria: 
1. Sex distribution    13.   Clinical Features 
2. Age distribution              a. Swelling 
3. Kaalam                           b. Tenderness 
4. Paruva Kaalam            c. Body Mass Index 
5. Thinai      14. Radiological Findings 
6. Duration of the illness   15. Disturbances in Vatham 
7. Socio-economic status   16. Disturbances in Pitham 
8. Occupational status     17.  Disturbances in Kabam 
9. Diet references     18. Udal kattugal  
10. Mode of Onset    19. Envagai Thervugal 
11. Precipitating Factors   20. Neikuri Analysis  
12. Associated diseases    21. Yakkai Ilakkanam  
       22. Assessment of effect of  
Therapy 
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1. SEX DISTRIBUTION: 
 
 
Among 20 cases, 5 were males and 15 were females. 
 
 
 
 
2. AGE DISTRIBUTION: 
 
 
 
 
 
 
 
 
 Most of the cases were above the age group of 50.  No one was reported 
below the age group of 40 during the study. 
S.No Sex No. of  Cases Percentage 
1. Male 5 25% 
2. Female 15 75% 
S. No. Age No. of  Cases Percentage 
1. 46-50 2 10% 
2. 51-55 3 15% 
3. 56-60 9 45% 
4. 61-65 5 25% 
5. 66-70 1 5% 
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3. KAALAM: 
 
Most of the cases 95% were in Pitha Kaalam and the rest were reported 
in Kapha Kaalam.  
No cases were reported in Vatha Kaalam. 
S.No Kaalam 
No. of  
Cases 
Percentage 
Total 
Percentage
1. Vatham  0-11 
              11-22 
              22-33 
- 
- 
- 
- 
- 
- 
0 
2. Pitham   33-44 
              44-55 
              55-66 
- 
5 
14 
- 
25% 
70% 
95% 
3. Kapham 66-77 
              77-88 
             88-100 
1 
- 
- 
5% 
- 
- 
5% 
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4. PARUVA KAALAM: 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
The maximum incidence of Azhal Keelvayu was during the Muthuvenil 
Kaalam and Kaar Kaalam.  No cases were reported in Munpani and Pinpani 
Kaalam. 
5. THINAI (PLACE): 
 
 
 
 
 
 
 
Among the 20 cases, majority were from Marutha Nilam.   
 
S.No Paruvakaalam No. of  Cases Percentage 
1. 
Kaar (Aavani, Purattasi) 
(Aug16-Oct15) 
7 35% 
2. 
Koothir (Iypasi, Karthigai) 
(Oct16-Dec15) 
1 5% 
3. 
Munpani (Margali, Thai) 
(Dec16-Feb15) 
- - 
4. 
Pinpani (Masi, Pankuni) 
(Feb16-Apr15) 
- - 
5. 
Elavenil (Chithirai, Vaikasi) 
(Apr16-June15) 
5 25% 
6. 
Muthuvenil (Aani, Aadi) 
(June16-Aug15) 
7 35% 
S.No Thinai No. of Cases Percentage 
1. Kurinji (Hill area) 1 5% 
2. Mullai (Forest area) - - 
3. Marutham (Fertile area) 15 75% 
4. Neithal (Costal area) 4 20% 
5. Paalai (Desert area) - - 
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6. DURATION OF ILLNESS: 
 
 
 
 
 
 
 
 
 Among the 20 cases, most of them had the duration of the illness 6 
months and above. 
 
 
 
7. THE SOCIO-ECONOMIC STATUS: 
  
 
 
 
 
 
According to this study 75% of the cases were poor socio-economic 
status, 25% cases were from middle class families. 
S.No Duration (Months) No. of Cases Percentage 
1. 3-6 4 20% 
2. 6-12 5 25% 
3. 12-24 8 40% 
4. 24-36 3 15% 
S.No Socio-economic status No. of Cases Percentage 
1. Poor 15 75% 
2. Middle class 5 25% 
3. Rich - - 
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8. OCCUPATIONAL STATUS: 
  
 
 
 
 
 
 
 Occupational status shows agriculturists and home makers were more 
affected. 
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9. DIET REFERENCE: 
 
 
 
 
  
 When the cases for clinical trail were enquired about their dietary habits 
it was noted that 80% cases had mixed diet habits. 
S.No Nature of Work No. of Cases Percentage 
1. Agriculturist 9 45% 
2. Manual labour 3 15% 
3. Home Makers 7 35% 
4. Watchman 1 5% 
S. No. Diet Habit No. of Cases Percentage 
1. Vegetarian 4 20% 
2. Mixed diet 16 80% 
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10. MODE OF ONSET: 
 
 
 
 
 
According to this study 100% of cases were reported gradual onset of 
disease. 
 
11. TABLE SHOWING PRECIPITATING FACTORS: 
 
S. No. Precipitating Factors No. of Cases Percentage 
1. Exposure to cold - - 
2. Over use of the joint 15 75% 
3. Over Weight 16 80% 
4. Trauma 4 20% 
5. Hereditary - - 
 
Among the 20 patients 15 of them (75%) had the history of over use of 
the joint 16 of them (80%) were over weight. 
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S. No. Mode of onset No. of Cases Percentage 
1. Acute - - 
2. Gradual 20 100% 
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12. ASSOCIATED DISEASES: 
 
S. No. Associated Diseases No. of cases Percentage 
1 Diabetes mellitus  2 10% 
2 Hyper tension 4 20% 
3 Rheumatoid arthritis - - 
 
 Among the 20 cases 4 cases were hypertensive and 2 of them were 
diabetic. 
 
13.TABLE SHOWING CLINICAL FEATURES: 
 
 
 
 
 
 
 
 
 
  
 
 
Among the twenty cases all of them had pain and tenderness. 18 patients 
had crepitation and 15 patients had morning stiffness.  80% of the patients had 
constipation and 90% had painful limited movements. 
S.No Signs and Symptoms No. of Cases Percentage 
1. Pain, tenderness 20 100% 
2. Swelling 14 70% 
3. Morning stiffness 15 75% 
4. Crepitations 18 90% 
5. Muscle Wasting 2 10% 
6. Deformity 2 10% 
7. Constipation 16 80% 
8. Loss of appetite 12 60% 
9. Limited Movements 18 90% 
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CLINICAL FEATURES
0%
20%
40%
60%
80%
100%
120%
Pa
in,
 te
nd
ern
es
s
Sw
ell
ing
Mo
rni
ng
 st
iffn
es
s
Cr
ep
ita
tio
ns
Mu
sc
le 
W
as
tin
g
De
for
mi
ty
Co
ns
tip
ati
on
Lo
ss
 of
 ap
pe
tite
Lim
ite
d M
ov
em
en
ts
Signs & Symptoms
Pe
rc
en
ta
ge
Series1
 
 
a) Measurement of swelling at joint line (Knee) in cm 
S.No Patient Name 
IP 
No 
Age 
/ Sex
Before Treatrment 
After 
Treatment 
Right Left Right Left 
1 Arumugathammal 1548 59/F 38 37 36 36 
2 Madathi 1637 51/F 31 30.5 31 30.5 
3 Mupidathiammal 1766 55/F 36.5 37 36 36.5 
4 Chellaiah 1792 61/M 41 41 40.5 41 
5 Issakiammal 1894 66/F 37 38 37 37.5 
6 Madakannu 1914 55/F 34.5 34 34 34 
7 Vadivu 1998 60/F 34.5 34.5 34 34 
8 Vembu 2185 60/M 35 37 35 35.5 
9 Rukmani 2218 52/F 31 31 30.5 31 
10 Malaiammal 2569 54/F 37 38 36.5 37.5 
11 Ranjitham 2312 55/F 45.5 43.5 45 43 
12 Ambrose 2406 54/M 35 37 34.5 36.5 
13 Vellammal 2533 55/F 35 34.5 34 34 
14 Poongani 2619 55/F 37.5 36 37 36 
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b) Tenderness at joint line (Knee) 
S.No Patient Name Age / 
Sex 
IP.No Before 
Treatment in 
Grades 
After 
Treatment in 
Grades 
1 Arumugathammal 59/F 1548 II I 
2 Madathi 51/F 1637 I Nil 
3 Mupidathiammal 55/F 1766 I Nil 
4 Chellaiah 61/M 1792 II Nil 
5 Issakiammal 66/F 1894 II I 
6 Madakannu 55/F 1914 II Nil 
7 Vadivu 60/F 1998 II Nil 
8 Vembu 60/M 2185 III I 
9 Rukmani 52/F 2218 III I 
10 Malaiammal 54/F 2569 II Nil 
11 Ranjitham 55/F 2312 II I 
12 Ambrose 54/M 2406 II Nil 
13 Vellammal 55/F 2533 II Nil 
14 Selvam 55/M 1384 II I 
15 Valliammal 57/F 1195 III II 
16 Shunmugasundram 57/M 1269 II I 
17. Uma Parvathi 45/F 1410 III I 
18. Valliamma 51/F 1633 III II 
19. Shakunthala 47/F 2782 III II 
20. Poongani 55/F 2619 II Nil 
 
Assessment of joint tenderness  
Grade I : The patient says the joint is tender 
Grade II : The patient winces 
Grade III : The patient winces and withdraws the affected part 
Grade IV : The patient will not allow the joint to be touched.
82 
 
c)  Body Mass Index: 
S. 
No. 
I.P. 
No. 
Before Treatment After Treatment 
Weight 
(kg) 
Height 
(meters)
BMI 
Weight/(height)2
Weight 
(kg) 
Height 
(meters) 
BMI 
Weight/(height)2
1 1195 70 1.60 27.34 69 1.60 26.95 
2 1269 73 1.65 26.81 73 1.65 26.81 
3 1410 69 1.55 28.72 69 1.55 28.72 
4 1384 70 1.68 24.80 70 1.68 24.80 
5 1633 65 1.58 26.03 65 1.58 26.03 
6 1548 68 1.60 26.56 68 1.60 26.56 
7 1637 65 1.50 28.88 65 1.50 28.88 
8 1766 68 1.61 26.23 67 1.61 25.84 
9 1792 69 1.58 27.63 68 1.58 27.23 
10 1894 70 1.60 27.34 70 1.60 27.34 
11 1914 62 1.52 26.83 62 1.52 26.83 
12 1998 65 1.58 27.76 65 1.58 27.76 
13 2185 68 1.69 23.80 68 1.69 23.80 
14 2218 67 1.60 26.17 67 1.60 26.17 
15 2569 62 1.58 24.83 62 1.58 24.83 
16 2312 63 1.58 25.23 63 1.58 25.23 
17 2406 60 1.62 22.86 60 1.62 22.86 
18 2583 64 1.63 24.08 64 1.63 24.08 
19 2619 65 1.57 26.37 65 1.57 26.37 
20 2782 65 1.59 25.71 64 1.59 25.31 
 
B.M.I. Ranges 
 Acceptable range - 18.5 - 24.90 
 Over weight  - 25.0 - 29.90 
 Obese   - 30.0 - 39.90 
 Morbidly obese - > 40 
 Among 20 cases 15 cases were over weight.  
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14. RADIOLOGICAL FINDINGS: 
 
S. No. Findings No. of Cases Percentage 
1 Joint Space narrowing 20 100% 
2 Inter condylar notch 
prominence 
14 70% 
3 Presence of Osteophytes 18 90% 
4 Subchondral Sclerosis 16 80% 
5 Osteoporosis 4 20% 
6 Deformity 2 10% 
7 Soft tissues swelling 2 10% 
 
 
Joint Space narrowed in all cases (100%), Osteophytes present in 18 
cases (90%). 
 
15. DISTURBANCES OF VATHA: 
Table showing the derangement of vatham: 
 
 
 
 
 
 
 
 
 
B
Both Viyanan and Samanan were affected in all the twenty cases 
(100%). 
Abanan was affected in 16 cases (80%). 
S. No. Vatham No. of Cases Percentage 
1. Pranan - - 
2. Abanan 16 80% 
3. Viyanan 20 100% 
4. Uthanan - - 
5. Samanan 20 100% 
6. Naagan 2 10% 
7. Koorman 4 20% 
8. Kirukaran - - 
9. Devathathan 11 55% 
10. Dhananjeyan - - 
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Devathathan was affected in 11 cases (55%). 
Koorman was affected in 4 cases (20%). 
Naagan was affected in 2 cases (10%). 
16. DISTURBANCES IN PITHAM: 
Table showing the derangement of Pitham: 
 
 
 
 
 
 
 
 
 
Saathaga Pitham was affected in all 20 cases (100%). 
Analapitham was affected in 12 cases (60%). 
 Ranjagam was affected in 7 (35%). 
 
17. DISTURBANCES IN KAPHAM: 
Table showing the derangement of Kapham: 
 
 
 
 
 
 
 
In all the 20 cases (100%) Santhigam was affected and so Avalambagam 
was also affected. Kiletham was affected in 12cases (60%). 
S. No. Pitham No. of Cases Percentage 
1. Analapitham 12 60% 
2. Ranjagam 7 35% 
3. Saathagam 20 100% 
4. Prasagam - - 
5. Alosagam 4 20% 
S.No Kapham No. of Cases Percentage 
1. Avalambagam 20 100% 
2. Kiletham 12 60% 
3. Pothagam - - 
4. Tharpagam 4 20% 
5. Santhigam 20 100% 
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18.TABLE SHOWING THE CONDITION OF UDAL KATTUGAL: 
 
 
 
 
 
  
 
 
 
 
In all the cases Saaram, Kozhuppu, Enbu and Moolai were affected (100%). 
Senneer was affected in 7 cases (35%). 
Oon was affected in 2 cases (10%). 
 
19.ENNVAGAI THERVUGAL: 
 
 
 
 
 
 
 
 
 
 
  Naadi   –  Vatha Pitham – 12 cases (60%). 
Pitha Vatham – 5 cases (25%) 
Pitha Kapham – 3 cases (15%) 
Naa was affected in 7 cases (35%), Malam was affected in 16 cases 
(80%).  
S.No Udal Kattugal No. of Cases Percentage 
1. Saaram 20 100% 
2. Senneer 7 35% 
3. Oon 2 10% 
4. Kozhuppu 20 100% 
5. Enbu 20 100% 
6. Moolai 20 100% 
7. Venneer/Suronitham - - 
S.No Ennvagai thervugal No. of Cases Percentage 
1. Sparisam 4 20% 
2. Naa 7 35% 
3. Niram - - 
4. Mozhi - - 
5. Vizhi 4 20% 
6. Malam 16 80% 
7. Moothiram - - 
8. Naadi 20 100% 
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20. NEIKURI: 
Among the 20 cases, the Neikuri result were observed as follows: 
 
 
 
 
 
 
21. YAKKAI ILAKKANAM (PHYSICAL CONSTITUTION): 
 
 
 
 
 
 
 
All the 20 cases were of Thontha udal. Out 20 cases 14 belong to vatha 
pitha udal and 6 belong to pitha vatha udal 
 
22. ASSESSMENT OF EFFECT OF THERAPHY 
Remarkable Effect 
 No longer any clinical manifestations. 
 Patient could work and live normally 
 No recurrence after some months. 
Moderate Effect 
 Marked reduction of manifestations. 
 Slight pain after movement 
Poor Effect 
 Slight reduction in the clinical manifestation 
 With relapse 
S.No Neikuri No. of Cases Percentage
1. Spreading like a snake 6 30% 
2. Spreading like a ring 7 35% 
3. Spreading like a pearl 7 35% 
S.No Yakkai Ilakkanam No. of Cases Percentage 
1. Vatha udal - - 
2. Pitha udal - - 
3. Kapha udal - - 
4. Thontha udal 20 100% 
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Observation: 
 60% of the cases showed good prognosis clinically.  
 
EFFECT OF THERAPY
45%
35%
20%
Remarkable
Moderate
Mild
Effect of 
therapy 
No. of cases Percentage 
Remarkable 9 45% 
Moderate 7 35% 
Mild 4 20% 
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DISCUSSION 
 
 This retrospective review of the disease Azhal Keel Vayu begins from 
the correlation of Azhal Keel Vayu with signs and symptoms of the disease 
Osteoarthritis and then initial sorting the information among the data extracted 
for the analysis include age, sex, duration of presenting symptoms, pre 
disposing or precipitating factors that provoked attack and their radiological 
findings. 
 The drugs used for this clinical trial are PERATHAI CHOORANAM 
(Nguuj;ijr; #uzk;) internally and NATHAICOORI ENNAI (ej;ijr;#hp 
vz;nza;) externally.  The detailed discussion of this dissertation topic by the 
author is based on the results and observation.  
Sex Distribution: 
 Among the twenty cases, 5 (25%) were male and 15 (75%) were female 
patients.  Common cause for this may be entrapping of calcium from body 
above 50 years of age due to oestrogen deficiency. 
Age distribution: 
 According to this study most of the patients were above the age of 50.  
which was already explained by modern science that degeneration due to 
ageing is important cause for osteoarthritis. 
  ‘Ntzlh itk;gjhk; taJ jd;dpy; 
   tpiue;J gpUjptpapy; mg;G NkTk; ghNu 
   NkitapNy Tly ;jsUk; mg;G nrd;W  
   tpsq;Fkzy;jid Nehf;fp ntSf;Fk; Nuhkk;.” 
        - Neha;ehly; I 
Menstrual History 
 Post menopause is one of the criteria which increases the incidence of 
the disease (90%) in females. 
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Prevalence of affecting the joints: 
 In Azhal Keelvayu the hallmark of involvements are articular joints, 
predominantly Knee Joint (100%).  
Duration of the illness: 
 According to this study the duration of the illness varied from 3 months 
to 2 years.  Naturally, this disease is a chronic one unless any history of trauma.  
Socio-economic status: 
 Among the 20 cases selected for this study, 15 cases (75%) were poor 
class and only 5 cases (25%) were middle class family. 
Occupation status: 
 Occupation place the important role in the aetiology of Azhal Keel 
Vayu.  Agricultural labour account for 45% cases.  Home makers and 
weightbearing workders were also affected by the disease.  The main cause for 
symptoms in these people were prolonged standing and distant walking. 
  ‘jfuNt ntFJ}u topelf;fpy; 
   espuhd fhw;WNk gdpNky; gl;lhy;” 
 - A+fp rpe;jhkzp  
Precipitating Factors: 
 Ageing is the common cause for Azhal Keel Vayu.  Apart from that 
occupation takes the major part 100% of the causative factor.  
Clinical manifestation: 
 The major clinical symptom reported  to be pain  in the joints and 
tenderness along joint line (100%) followed by crepitation in the knee joints 
(90%) 80% of them had constipation  75% of them had morning stiffness of 
limited duration and 70% had swelling in knee joint.  
Seasonal distribution : 
 Muthuvenil kalam and Kaar Kalam shows the highest incidence of 35%  
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 ‘gJkj;ijg; G+f;fitf;Fk; ghDkpf;f fhAk;  
KJNtzp ypw;AtpePh; Kw;Wk; - fJnkd 
tw;Wk; fgk; ‡Fk; thAkpFk; tho;khe;jh;f; 
Fw;w eypf; Nfjpnjd; NwhJ.  
     - kUj;Jt jdpghly; 
 
 KJNtdpw; gUtj;jpy; #hpa ntg;gk; mjpf 
fLikahapUf;fpd;wikahy; cyfj;jpYs;s vy;yhg; nghUl;fspd; 
ePh;g;ghfKk; ngUk;ghYk; ,Of;fg;gl;L cyh;tJNghy> caph;fspd; 
clypYs;s NfhioAk; ,Of;fg;gl;Lr; rPuzkhFk;.  ,jdhy; thjk; 
ngUfp> td;ikAs;s thjg; gpzpfs; tYf;Fk;.  
 Kaar Kallam Shows 35% incidence.  
‘jpLnkdf; Fsph;e;J ePh;j; jptiyiar; Rke;jdpyk; 
 rpyh;j;jpl cytyhy; cly; tsp ngUFkpk;kz;’ 
- kUj;Jt jdpghly; 
vjph;ghuhj tpjkha; Fsph;e;j ePh;j;Jspfs; jhq;fpa fhw;W tPr 
clypd; thjk; kpFe;J thjk; gpzpfs; Njhd;Wk;.      
Living lands: 
 The incidence of Azhal Keelvayu is hight in people from Martutha 
Nilam (75%) and Neithal Nilam (20%) 
 Generally in martha nilam, all the three doshas are in physiological 
ratio, but for these 75 patients the occupation and age alter the physiological 
ratio and cause the disease.  
Diet : 
 Diet plays a major role in maintaining ideal body mass index.  Majority 
of the people (80%) were non-vegatarians.  Almost all the patients were fond of 
eating high calorific food like snacks, deep fried items the calorics consumed 
excels the calories burnt which results in obesity. Out 20 patients, 15 were 
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overweight – (ie)  the body mass index is higher than the acceptable range.  
This was aptly explained by Yugi.  
‘epfuNt fha;fs; fdp fpoq;F jd;id 
kpf tUj;jp japh;j;jhd; nfhz;lhy;  
 KfuNt KJnfhYk kPwpNa;G KWf;fp nehe;J. 
  Koq;fhYk; fZf;fhYk; fLg;Gz;lhFk;.” 
        - A+fp rpe;jhkzp.  
Disturbance in Vatham: 
 In the twenty cases, in all of them (100%) Viyanan and Samanan were 
affected.  Abanan was affected in 16 (80%) cases.  Devathathan was affected in 
11 cases (55%).  Koorman was affected in 4 cases (20%).   
Disturbance in Pitham: 
 According to this study, Sathagapitham was affected in all 20 cases 
(100%) Analapitham in 12 cases (60%) and Ranjagapitham  in 7 (35%) cases.  
Disturbance in Kapham: 
 According to this study santhiga kapham was affected in all the cases 
(100%).  Therefore Avalambagam also affected in 20 cases.  Kilethagam was 
affected in 12 (60%) cases. 
Udal Kattugal: 
 Among the Seven udal Kattugal, Saaram, Kozhuppu, Enbu and Moolai 
were affected in all 20 (100%) cases. Senneer were affected in 7 (35%).Oon 
was affected in 2 cases (10%). 
Derangement in eight parameters in our systems (Envagi thervugal) 
 According to this study, in Ennvagai thervugal, Naadi was affected in all 
the cases (100%), Naa was affected in 7cases (35%) Sparism was affected in 4 
cases (20%) Vizhi was affected in 4 cases (20%). 
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Laboratory Investigation: 
 The available laboratory investigations were done in the Govt. Siddha 
Medical College, Palayamkottai.  Routine examination of blood, urine and 
stools were done during the admission and discharge.  Examination of urine 
and stools showed no abnormalities.  All the shown values have been recorded 
in the Investigation table.  Anaemia was found in 7 cases (35%) .  there was not 
much remarkable changes if the total count, differential count and Erthyrocyte 
Sedimentation. 
Radiographic studies shows narrowed joint space, presence of 
osteophytes,osteoporotic changes and subchondral sclerosis. 
Associated diseases : 
 Out of 20 in patients cases treated, 2 cases were found to have  diabetes 
mellitus and 4 cases were found to have hypertensive.   
 These patients continued their oral anti-diabetic drugs namely  
Madhumegal Chooranam – 1gm  
Thribala Chooranam – 1gm  
Thrice a day with luke warm water.  Oral anti – hypertensive drugs, 
namely  
Asai chooranam – 1 gm  
Venthamarai Chooranam – 1gm  
Thrice a day with luke warm water which they were taking previously 
along with the trial drugs.  Their blood sugar levels were monitered and blood 
pressure recordings were noted and kept control during the treatment.  
 Effect of therapy 
On the basis of assessment of the curative effect of the trial 
drugs,Remarkable effect was recorded in 45% of cases.Moderate effect was 
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observed in 35% of cases.The trial drugs showed improvement in prognosis of 
the disease clinically rather than radiographically . 
BIOCHEMICAL ANALYSIS  
 Bio Chemical analysis of the trial drug was done in the Deparment of 
Bio-Chemistry, Government Siddha Medical College, Palayamkottai 
 Perarathai Chooranam contains,  
1. Calcium  
2. Sulphate  
3. Unsaturated compound 
4. Reducing sugar 
5. Amino acid.  
No toxic or side effects were clinically observed in any cases.  
Calcium is essential for growth, as it plays an important role in the 
formation of bones. 
Sulphates acts by converting toxic substances into non toxic materials 
by means of conjugation. It is also found as a part of glucosamine and 
chondroitin sulphate found in healthy bones and cartilages. 
Amino acids – Sodium co-transport of amino acids occurs during the 
absorption of amino acids from the intestine into the blood and during the 
reabsorption from renal tubule into blood. Amino acids facilitate absorption of 
calcium. 
Reducing Sugar enhances absorption of Calcium, Iron amd other 
nutrients in the food. 
94 
 
PHARMACOLOGICAL ANALYSIS : 
 Pharmacological studies done in Pharmacology Department of 
Government Siddha Medical College, Palayamkottai.  The results were 
reported as follows.  
Internal Medicine:  
Perarathai Chooranam (Nguuj;ijr; #uzk;) 
a) Significant Analgesic effect 
b) Significant Acute Anti – inflammatory effect 
c) Significant Chronic Anti – inflammatory effect.  
External Medicine : 
 Nathaichoori Ennai (ej;ijr;#hp vz;nza;) has significant Anti – 
inflammatory action.  
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SUMMARY 
 
Fifty five cases with Azhal Keelvayu, diagnosed clinically.  Out of them 
thirty cases were admitted in the in-patient PG Sirappu Maruthuvam Ward, 
Govt. Siddha Medical College Hospital, Palayamkottai were observed for 
clinical diagnosis, lab diagnosis and treatment by the trial medicines.  Out of 
them twenty cases were selected for study. Twenty five cases were treated as 
out patients. 
1. Clinical diagnosis of Azhal Keel vayu was done on the basis of clinical 
features described in Sabapathi Manuscript . 
2. Before starting the treatment, careful detailed history was taken out and 
recorded for the 20 seleceted cases.  
3. The various Siddha aspects of examination of the disease were carried 
out and data were recorded in the proforma.  
4. Laboratory diagnosis of Azhal Keelvayu was done by modern methods 
of examination in the Govt. Siddha Medical College Hospital, 
Palayamkottai. 
5. The trial medicine chosen for both internal and external treatment and 
the management of Azhal Keelavayu  
• Perarathai chooranam as per the severity of the complaints, the 
dosage were given 1 gm two times a day with luke warm water for 
twenty days and above. 
• Nathaichoori Ennai (Externally). 
6. During the period of treatment, all the patients were put under strict 
pathiyam-a specific dietary regimen. 
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7. The observation made during the clinical study shows that the main drug 
Perarthai chooranam (Internally) is clinically effective. It has moderate 
analgesic action and significant anti inflammatory action.  
8. The action of Nathaichoori Ennai (Externally) over the affected joint 
was also clinically effective.It has Significant anti inflammatory action. 
9. A periodical laboratory investigation were made for all the case for 
blood, urine and motion test etc., along with radiological reports. 
10. Since Azhal Keel vayu is a chronic disease, it required minimum 
treatment for twenty days, treated both internally and externally to 
minimize the severe pain, tenderness and swelling, but also slight 
disappearance of the crepitation. 
11. Thoug there was appreciable clinical improvement, there was not much 
remarkable radiographic changes.  
12. The advantages of the selected drugs were listed as,  
¾ The drugs were found to be free from adverse effects.  
¾ The raw materials were available in almost all seasons.  
¾ And finally it is economic 
These merits were essential in promoting this drug in future globally.  
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CONCLUSION 
 
All the twenty patients Selected for this Study were treated with 
Perarthai chooranam  Internal 1gm twice day with luke warm water  and 
Nathaichoori Ennai   (Externally). 
 Clinical result shows improvement in 60% of the cases. 
Remarkable effect in 9 cases   - 45%.    
Moderate effect in 7 cases   -  35%  
Mild effect in 4 cases   - 20% 
 
This clinical result shows the effect of the trial drugs in the treatment of 
Azhal Keel Vayu. 
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ANNEXURE I 
 
cs;kUe;J : 
Nguuj;ijr; #uzk; : 
 Nguuj;ijia Jz;Lfshf;fp epoypy; cyh;j;jp> Rj;jp nra;J> 
nghbj;J rypj;J vLj;J nfhs;s Ntz;Lk;.  
Mjhuk; : Fzghlk; %ypif tFg;g gf;fk; vz; 28. 
#uzk; Rj;jp Kiw : 
 gRtpd; ghypy; gpl;ltpay; nra;J cyh;j;jp vLj;Jf;nfhs;s 
Rj;jpahFk;.  
Mjhuk; : kUj;J nra;,aYk; fiyAk; gf;fk; vz; 114.  
msT: 
 1fpuhk; ,UNtis> cztpw;F gpd; fhiy> ,uT 
mDghdk; : 
 Mwpa nte;ePh; 
ntspkUe;J : 
ej;ijr;#hp vz;nza;  
Njitahd ruf;Ffs;  
Kw;wpd ej;ijr; #hp Nth;  - 105 fpuhk; 
trk;G      - 26 fpuhk; 
G+z;L     - 8 fpuhk; 
Mkzf;nfz;nza;   - 1.3 ypl;lh; 
nra;Kiw : 
 ej;ijr; #hp> Nth;> trk;G> G+z;L ed;wha; eRf;fp> 
Mkzf;nfz;nzapw; fye;J gjkha; vhpf;fTk; vhpj;jgpd; tbfl;b 
itj;Jf;nfhs;sTk;.  
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jPUk; Neha; : 
 80 tif thj Neha;fs; fhy; tPf;fj;jpw;F NkNy Nja;j;J nte;ePhpy; 
Fspf;f FzkhFk;.  
Mjhuk; : ruNge;jpuh; itj;jpa Kiwfs; (thj Nuhf rpfpr;ir)  
gf;f vz; 1 
 
GUNAPADAM ASPECT 
PROPERTIES OF TRIAL DRUGS 
 
Nguuj;ij - Galangal the greater.  
jhutpay; ngah; : 
Alpinia galanga - Zingiberacceae / Scitaminae.  
gad;gLk; cWg;G  : Nth;  
Rit   : fhh;g;G 
tPhpak;  : ntg;gk; 
gphpT   : fhh;g;G 
nra;if  : Nfhiofw;wp 
     ntg;gfw;wp 
     grpj;jPJ}z;b 
nghJFzk; : 
 ‘thj kprpT typ re;jp gpj;ijaQ; 
 rPjRue; jhtpuzQ; nrhd;d eP - NghJgy  
 thq;fLg; G+g;glW khW nkhspahF 
 kPq;flUk; Nguuj;ij ahy;”  
       - mfj;jpah; Fzghlk;.  
 tspNeha;> cly;typ> Gwtyp> moiyak;> IaRuk;> Kg;gpzp> 
jiyg;Gz;> jiyapd; ePNuw;wk;> Fjftyp> eQ;rs; Mfpa ,itfisg; 
Nghf;Fk;.  
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Chemical constituents  
Rizome contains: 
1. 14 flavonoids – 7 – quercetin, kammferol , quercetion – 3 
methy ether, isorhammeth, kaenyeride, galangin and galangin 
– 3 – methyl ether.  
2. Alpinin 
3. Lyalangin 
4. Campheride 
5. Galanolactone 
6. 1-acetoxy chavichal acetate 
7. 1-acetoxy eugenal acctate 
8. 1-hydroxy chanical acetate.  
Compendium of Indian Medicinal plants (Vol-II, III, VI 
and V). 
Action : 
 Rhizone is useful in rheumatism.  
    Materia Medica – Dr.K. M. Nadkarni.  
 
ntspkUe;J  
ej;ijr;#hp vz;nza;  
NrUk; ruf;Ffs;  
ej;ijr; #hp - Spermacoce hispida – Rubiaceae  
   (Shaggy button weed).  
NtWngah; 
fLfk;> Fopkpl;lhd;> #hp> jhUzp> njhypahfuk;ik  
gad;gLk; cWg;G  :  Nth; 
Rit   :  ,dpg;G> Jth;g;G 
gphpT   :  ,dpg;G. 
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nra;if   :  cly;Njw;wp 
     cukhf;fp 
Fzk;   : Nth; cliyj; Njw;wk;  
Chemical constituments  
1. 3-Kato – olean – 12 en – 29oic acid.  
2. Olean – 12 ene 3 β-ol 29-oic acid.  
-Compendium of Indian Medicinal plants (Vol V) 
Action : 
 Roots used like sarsaparilla (Chronic rheumatism) 
-Materia Medica, Dr. K.M. Nadkarni. 
 
2.  trk;G – Sweet flag – Acorus calamus - Araceae  
It is a semi – aquatic perennial herb.  
gad;gLk; cWg;G  :  Nth; 
Rit    :  fhh;g;G 
jd;ik    :  ntg;gk;  
gphpT    :  fhh;g;G.  
nra;if    : mfl;Ltha;fw;wp 
     Fkl;lnyKg;gp 
     grpj;jPJ}z;b 
     Kiwntg;gfw;wp 
Fzk; : 
 ‘nts;spa trk;gpNyhL tphptrk; Gw;w ePh;ik  
 njs;spa fLNt jpf;jq; jpK\;zk; yFNt &fb 
 nkhs;spa fUtp ghf Kah;thj kpja NehA 
 nks;SW fgNk #iy apUky; ge;jk; gpd;Dk;.”  
- gjhh;j;j gQ;r Fz kQ;rhp 
 trk;G> nts;trk;G ,it thjk;> fgk;> ,Uja Nuhfk;> #iy> 
kyge;jk; Mfpatw;iw Nghf;Fk;. 
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Chemical Constituents : 
1. Acorin  - Glucoside 
2. Acoretin (Choline) - Bitter principle  
3. Calamin  - Alkaloid. 
4. Starch, Mucilage and tannin.  
5. α  - asarone, β - asarone. 
6. Calaemenone, Calamendiol and iso calemendiol.  
Compendium of Indian Medicinal Plants (Volume V) 
Action  
 Externally, it is used in chronic rheumatism.  
- Mataria Medica Dr. K.M. Nadkarni.  
 
3.  g+z;L : Garlic – Allium Sativum – Liliaceae 
NtWngah; :  fhak;> nts;tq;fhak;> ,yRdk;.  
gad;gLk; cWg;G : fpoq;F (Bulb)  
Rit  :  fhh;g;G 
jd;ik  :  ntg;gk;  
gphpT  :  fhh;g;G.  
nra;if  : mfl;Ltha;tfw;wp 
   cukhf;fp 
   ntg;gKz;lhf;fp 
   Nfhioafw;wp 
   rpWePh;g;ngUf;fp  
   GOf;nfhy;yp.  
Fzk; : 
 ‘re;jpnahL thje; jiyNehT jhs;typ 
 kd;dptU ePh;f;Nfhit td;rPjk; - md;dNk 
 cs;Ss;sp fz;gha; cis %y NuhfKk; Nghk;.  
 nts;Ss;sp jd;dhy; ntUz;L”  
- mfj;jpah; Fzthflk;.  
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Kg;gpzp> tspNeha;fs;> Iaj;jiytyp> tha;Neha;> ePNuw;wk;> 
rPjf;fopr;ry;> %yk; ,itfl;F nfhLf;fyhk;.  
Chemical constituents:  
1. Acid volatile oil contains allyl propyl disulphide, diallyl disulphide 
and polysulphides.  
2. Bulb Contains : 
1. Organo sulphur compound  -   ajoene 
2. furostanol glycoside  - i) Protoeruboside B 
      ii) Sativoside B.  
3. Allicin. 
4. Selenium containing polysaccharide – F – gitonin.  
Compendium of Indian Medicinal  plants. (Vol IV. V) 
 
4.  Mkzf;nfz;nza; : Castor – oil Ricinus communis- Euphorbiaceae 
Rit : fhh;g;G 
jd;ik : ntg;gk;  
gphpT : fhh;g;G.  
nra;if : thjklf;fp 
  kykpsf;fp 
  twl;rpafw;wp.  
Fzk; : 
 ‘Mkzf; nfz;nza; jd;id azpepy kwpaf; Nfz;kpd;. 
 G+kzr; re;JNjhWk; nghUe;jpa thjk; Nghf;Fk;.  
 jPke;je; jhDk; Nghf;Fe; jpfo;Tld; tpiuT Kz;lhk;. 
 jPkzf; Flypy; thjQ;Nrh;Fl Nyw;wk; NghNk.”  
- Fzghlk; - %ypif tFg;G.  
re;Jthjk; Nghf;Fk;.  
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Chemical constituents  
Fixed Oil contains  :  i)  45% - inert alkaloid – Ricinin, proteids.  
     ii) 20% starch, mucilage and sugar 
     iii) Poisonous aluminoid – ricin.  
Castor oil – Contains :  
Recinolein, Recinoleic acid, Palmitin, Stearin, Myristin and  Arid 
Principle.  
Action : 
Extermally  it is used for arthritis.  
- Mataria Medica Dr. K.M. Nadkarni 
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ANNEXURE II!
GOVT SIDDHA MEDICAL COLLEGE, 
PALAYAMKOTTAI 
BIO-CHEMICAL ANALYSIS 
Preparation of the extract: 
 5gms of choornam was weighed, accurately and placed in a 250ml clean 
beaker.  Then 50ml distilled water is added and dissolved well.  Then it is 
boiled well for about 10 minutes.  It was cooled and filtered in a 100ml 
volumentric flask and then it is made up to 100 ml with distilled water.  This 
fluid is taken for analysis. 
Qualitative analysis: 
S.No Experiment  Observation  Inference 
1. TEST FOR CALCIUM 
2ml of the above prepared 
extract is taken in a clean test 
tube.  Add 2 ml of 4% 
ammonium oxalate solution is 
added to it 
A white precipitate 
is formed  
Indicates the 
presence trace 
amount of calcium 
is present. 
2. TEST FOR SULPHATE 
2ml of the extract is added to 5% 
barium chloride solution 
A white precipitate 
is formed  
Indicates the 
presence of 
sulphate.  
3. TEST FOR CHLORIDE 
The extract is treated with silver 
nitrate solution 
No white 
precipitate is 
formed  
Absence of 
Chloride 
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4. TEST FOR CARBONATE  
The substance is treated with 
concentrated HCL. 
No brisk effer 
vessence is formed  
Absence of 
Carbonate 
5.  TEST FOR STARCH 
The extract is added with weak 
iodine solution 
No Blue colour is 
formed 
Absence of starch. 
6. TEST FOR IRON 
FERRIC: The extract is treated 
with glacial acetic acid and 
potassium ferro cyanide. 
No Blue color is 
formed 
Absence of ferric 
Iron 
7. TEST OF IRON FERROUS: 
The extract is treated with 
concentrated nitric acid and 
ammonium thio cyanate 
No blood red colour 
is formed  
Absence of ferrous 
iron. 
8. TEST FOR PHOSPHATE 
The extract is treated with 
ammonium Molybdate and 
concentrated nitric acid. 
No yellow 
precipitate is 
formed  
Absence of 
phosphate 
9. TEST FOR ALBUMIN 
The extract is treated with 
Esbach’s reagent. 
No yellow 
precipitate is 
formed 
Absence of 
Albumin. 
10. TEST FOR TANNIC ACID. 
The extract is treated with Ferric 
Chloride reagent.  
No blue back 
precipitate is 
formed. 
Absence of Tanmic 
acid. 
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11. TEST FOR UNSATURATION 
Potassium permanganate 
solution is added to the extract. 
It gets decolourised. Indicates the 
presence of 
unsaturated 
compound. 
12. TEST FOR THE REDUCING 
SUGAR. 
5ml of Benedict’s qualitative 
solution is taken in a test tube 
and allowed to boil for 2 mts and 
added 8-10 drops of the extract 
and again boil it for 2 mts. 
Colour change 
occurs. 
Indicates the 
presence of 
Reducing Sugar. 
13. TEST FOR AMINO ACID. 
One or two drops of the extract is 
placed on a filter paper and dried 
it well, after drying 1% 
Ninhydrin is sprayed over the 
same and dried it well. 
Violet colour is 
formed. 
Indicates the 
presence of Amino 
acid. 
 
Inference : 
 The trial drug “Perarathai Chooranam” contains Calcium, 
Sulphate, Unsaturated Compound, Reducing Sugar and Amino Acids. 
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ANALGESIC STUDY OF PERARATHAI CHOORANAM 
 
Aim    
To study the effects of analgesic action on albino rats by tail flick 
method. 
Instruments 
 Analgesiometer using heated nicrome wire as the source of stimulus. 
Procedure: 
 Two groups of rats on either sex were selected, each group having three 
rats and each rat was put inside a rat holder with the tail projecting out fully.  
The tip of the tail was kept over the nicrome wire of the analgesiometer.  To 
heat the nicrome wire by switching it on and at the same time starting a 
stopwatch.  The time takes for the rat to flick the tail was noted.  This was kept 
as the control volume. 
 Paracetamol was administered at a dose of 20mg/100gm of body weight 
orally to the test group.  The reaction time was noted after the administration 
half an hour and one hour and the average is calculated. 
 When a rat fails to flick the tail, it should be continued beyond eight 
seconds to avoid injury. 
The result of drug treated group and control group were tabulated and 
compared. 
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STUDY OF ANALGESIC EFFECT OF USING THE DRUG OF PERARATHAI CHOORANAM 
Group 
Dose/100mg 
Body weight 
Initial reading 
(in Sec ) 
After ½ hour 
(in Sec) 
After 1 hour 
(in Sec) 
 
After 1 ½  
hour 
(in Sec) 
 
Mean 
Difference 
Control Water 2ml 2.5 2.5 2.5 2.5 2.5 
Standard 
Paracetamol- 
20mg 
2.5 3.5 4.5 6.5 6.5 
Test drug 100mg 2.5 2.5 3.5 5 5 
 
Inference: 
 The trial drug have significant analgesic action 
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ACUTE ANTI-INFLAMMATORY ACTIVITY IN RATS 
BY HIND-PAW METHOD 
Aim: 
To demonstrate the acute anti-inflammatory activity of  PERARATHAI 
CHOORANAM in albino rats by Hind-paw method. 
Procedure: 
 Nine Albino rats weighing 100-150gm were taken and divided into three 
groups and each group consisting three rats. 
 First group was kept as control land received water.  Second group 
received lbuprofen at a dose of 20mg/100gm-body weight.  Third group 
animals received Perarathai chooranam suspension at a dose of 
200mg/100gm-body weight. 
 Before administration of drugs, the Hind-paw volume of all the rats 
were measured.  This was done by dipping the Hind-paw upto the ribio-tarsal 
junction in mercury plethysmograph.  Soon after the measurement at the drugs 
were administered.  One hour after the administration of drugs a sub-cutaneous 
injection of 0.1ml of 1%/W/V of carrageenin in water was made into planter 
surface of both the Hind-paw of each rat. 
Three hours after carrageenin injection, the Hind-paw volume was 
measured once again.  Difference between the initial and final value were noted 
and compared. 
This method is more suitable method for studying anti-inflammatory 
activity in acute inflammation. 
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THE EFFECT OF PERARATHAI CHOORANAM IN ACUTE                
ANTI-INFLAMMATORY ACTIVITIES 
 
Group 
Dose volume 
orally 
Initial 
reading
Final 
reading
Mean 
difference
Percentage 
Inflammation 
Percentage 
Inhibition 
Control Water 2 ml 1.1 1.85 0.75 100 - 
Standard 
Ibuprofen 
20mg/100gm 
1.3 1.3 0.05 6.6 93.4 
Test 
drug 
200mg/100gm 1.0 1.25 0.25 33.3 66.7 
 
Result: 
 The drug Perarathai chooranam has significant acute anti - 
inflammatory action. 
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CHRONIC ANTI-INFLAMMATORY STUDY                          
BY COTTON-PELLETS GRANULOMA METHOD 
Drug 
 Perarathai Chooranam 
Aim 
 To study the chronic anti-inflammatory activity of the drug in albino rats 
by cotton pellets implantation (granuloma) method. 
Procedure: 
 Cotton pellets each weighing long was prepared and sterilized in an 
autoclave for about one hour under 15 lbs atmosphere pressure.  Nine Albino 
rats weighing between 100-200gm were selected and were divided into 3 
groups.  Each rat was anaesthetized with ether and cotton pellets were 
implanted subcutaneously in the groin, two in each side. 
 From the day of implantation, one group of animals received Perarathai 
Chooranam at a dose of 200mg/100gm of body weight.  
 On the eighth day the rats were sacrificed and the pellets were removed 
weighed.  Then they were put in an incubator at 60ºC-80ºC and then weighed. 
The concordant weight was noted for all groups and compared. 
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THE EFFECT OF PERARATHAI CHOORANAM IN CHRONIC             
ANTI - INFLAMMATORY STUDY 
Group 
Dose given 
orally 
Pellet 
Weight 
Pellet 
Weight of 
the 
Granuloma 
of drugs 
Percentage 
inflammation 
Percentage 
inhibition 
Control Water 2ml 10mg 250mg 100 - 
Standard 
Ibuprofen 
20mg/100gm 
body weight 
10mg 
 
 
55mg 
 
22 
 
78 
Test 
drug 
200mg/100gm 
body weight 
10mg 98mg 40 60 
 
Inference : 
 The drug show significant chronic anti - inflammatory action. 
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ACUTE ANTI – INFLAMMATORY STUDY ON            
NATHAI CHOORI ENNAI (EXTERNAL USE)                         
BY HIND-PAW METHOD IN ALBINO RATS 
Aim: 
 To study the acute anti-inflammatory activity of the test drug  NATHAI 
CHOORI ENNAI. 
Preparation of the test drug: 
 The Nathai Choori Ennai was prepared as per the preparation in 
Sarabhendra Vaidhya Muraigal – Vatha Rogha Chikichai (Page 1). 
Procedure: 
 Six healthy albino rats weighing 100-150gm were taken and divided into 
three groups, each consisting of 2 rats. 
 First group was kept as control by giving distilled water of 2ml/100gm 
of body weight.  The second group was kept as test group.  The third group was 
given the standard drug. 
 Before application of the test drug the Hind-paw volume of all the rats 
were measured.  This was done by dipping the Hind-paw (up to the tibio-
femoral junction) into a mercury plethysmograph.  While dipping the Hind-
paw, by pulling the syringe piston, the level of mercury in the centre small tube 
was made to coincide with red marking and reading was noted from the 
plethysmograph. 
 One hour later, a sub-cutaneous injection of 0.1ml of 1%(w/r) 
Carrageenin water made into  plantar surface of both Hind-paw of each rat.  To 
the second (last) group Nathai Choori Ennai was topically applied for three 
times over the inflammed surface in a thin layer for every 15mts for an hour.  
To the other group no drug was applied over the inflammed surface. 
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 Three hour after injection the Hind-paw volume was measured once 
gain.  The difference between the initial and final volume would show the 
amount of inflammation.  Taking the volume in the control group as 100% of 
inflammation, anti-inflammatory effect of the test group is calculated. 
EFFECT OF NATHAI CHOORI ENNAI 
Group Drugs 
Dose 
100gm 
of 
body 
weight 
Initial 
value 
Final 
value
Difference
Percentage 
Inflammation 
Percentage
Inhibition 
Control Water 2ml 1.1 1.85 0.75 100 - 
Standard Ibuprofen 20ml 1.3 1.35 0.05 6.6 93.4 
Test 
drug 
Nathaichoori  
Ennai 
Ext 1.0 1.3 0.3 33.3 66.7 
 
Inference: 
 The test drug has significant anti -inflammatory action externally. 
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PROFORMA OF CASE SHEET 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI. TRIRUNELVELI – 627 002 
Branch – III Sirappu Maruthuvam 
Dissertation done by: 
I.P. No  :  Occupation   : 
Bed No  :  Income   : 
Ward   :  Nationality   : 
Name   :  Religion   : 
Age   :  Date of Admission  : 
Sex   :  Date of Discharge  : 
Permanent Address :  Diagnosis   : 
     Result    : 
     Medical Officer  : 
 
Complaints and duration: 
 
History of present illness: 
 
History of Previous illness: 
 
Personal history including habits: 
 
Family History  : 
Socio Economical Status : 
Menstrual History  : 
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GENERAL CONDITIONS ON EXAMINATION 
 
1. Consciousness   : 
2. General appearance  : 
3. Nourishment   : 
4. Anaemia    : 
5. Jaundice    : 
6. Cyanosis    : 
7. Clubbing    : 
8. Lymphadenopathy  : 
9. Jugular Venous Pulsation : 
10. Pedal oedema   : 
11. Temperature   : 
12. Pulse    : 
  Rate   : 
  Rhythm  : 
  Volume  : 
  Character  : 
  peripheral pulses : 
  Pulses paradoxus : 
     
13. Respiratory Rate  : /min 
14. Heart Rate   : /min 
15. Blood pressure   : 
16. Miscellaneous   : 
 Body Weight   
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rpj;j Kiw NjHT 
1. epyk;  
 FwpQ;rp 
 Ky;iy 
 kUjk; 
 nea;jy; 
 ghiy 
2. gUt fhyk; 
 fhH fhyk;   (Mtzp - Gul;lhrp) 
 $jpH fhyk;  (Ig;grp - fhHj;jpif) 
 Kd;gdp   ( khHfop - ij 
 gpd;gdp   ( khrp- gq;Fdp) 
 ,sNtdpy;  ( rpj;jpiu - itfhrp) 
 KJNtdpy;  ( Mdp - Mb) 
3. ahf;if (cly;) 
 thjk; 
 gpj;jk; 
 fgk; 
 fyg;G 
4. Fzk; 
 rj;Jtk; 
 ,uhrjk; 
 jhkrk; 
5. nghwp Gyd;fs; 
 nka; - CW 
 tha; - Rit 
 fz; - xsp 
 %f;F - ehw;wk; 
 nrtp - xyp  
119 
 
6. fd;Nke;jphpak; 
 if - jhdk; 
 fhy; - fkdk; 
 tha; - trdk; 
 vUtha; - tprHf;fk; 
 fUtha; - Mde;jk; 
7. cl;fhak; 
 Njhs; nghUj;J 
 Gak; 
 Koq;if nghUj;J 
 rak; 
 iff;FsR 
 fugk; 
 mq;Fyp 
8. mjf;fhak; 
 ,Lg;G nghUj;J 
 njhil 
 Koq;fhy; nghUj;J 
 Kd;fhy; 
 Fjpq;fhy; 
 fugk; 
 mq;Fyp 
9. tk;rp 
10. Kk;kyk; 
 kyk;    - 
 %j;jpuk;   - 
 tpaHit   - 
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11. gpw cWg;Gfspd; epiy 
 ,Ujak;   - 
 Gg;Grk;   - 
 ,iug;ig   - 
 fy;yPuy;   - 
 kz;zPuy;   - 
 rpWFly;   - 
 ngUq;Fly;   - 
 rpWePufk;   - 
 %is   - 
 fUg;ig   - 
 
12. capH jhJf;fs; 
(m) thjk;    - 
 gpuhzd;   - 
 mghdd;   - 
 tpahdd;   - 
 cjhdd;   - 
 rkhdd;   - 
 ehfd;   - 
 $Hkd;   - 
 fpUfud;   - 
 Njtjj;jd;   -  
 jdQ;nrad;  - 
(M) gpj;jk; 
 mdw; gpj;jk;  - 
 ,uQ;rf gpj;jk;  - 
 rhjf gpj;jk;  - 
 MNyhrf gpj;jk;  - 
 gpuhrf gpj;jk;  - 
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(,) fgk; 
 mtyk;gfk;   - 
 fpNyjfk;   - 
 Nghjfk;   - 
 jw;gfk;   - 
 re;jpfk;   - 
 
13. cly; jhJf;fs; 
 rhuk;    - 
 nre;ePH   - 
 Cz;    - 
 nfhOg;G   - 
 vd;G    - 
 %is   - 
 Rf;fpyk;/RNuhzpjk; - 
14. vz; tifj;NjHTfs;  
 ehb    - 
 ];ghprk;   - 
 eh    - 
 epwk;    - 
 nkhop    - 
 tpop    - 
kyk; 
 epwk;    - 
 vil    - 
 ,Wfy;   - 
 ,sfy;   - 
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rpWePH 
1. ePHf;Fwp 
 epwk;    - 
 kzk;    - 
 vil    - 
 Eiu    - 
 vQ;ry;   - 
2. nea;f;Fwp 
 
LABORATORY INVESTIGATION 
Before Treatment    After  Treatment 
 
1. BLOOD: 
TC : cells/ cu. mm 
DC :    P %  
L %  
E %  
M % 
ESR : 
  ½ hour : mm 
   I hour  : mm 
Hb   : 
Blood Sugar  : 
Blood Urea  : 
Serum Cholesterol : 
Uric Acid  : 
VDRL  : 
2. URINE 
 Albumin  : 
 Sugar   : 
 Deposits  : 
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3. Motion 
 Ova   : 
 Cyst   : 
4. IMMUNOLOGICAL : 
 RA Factor  : 
5.RADIOGRAPHIC FINDINGS : 
6. SEROLOGICAL TEST FOR SYPHILIS : 
7. SYNOVIAL FLUID ANALYSIS : 
8. ARTHROGRAPHY : 
EXAMINATION OF  LOCOMOTOR SYSTEM 
INSPECTION 
Overlying Skin: 
 Colour   : 
 Scars and ulcers  : 
 Periarticular swelling : 
 Deformity   : 
 Unusual posture  : 
 Muscle changes  : 
 Symmetrical distribution : 
 Gait    : 
Palpation: 
 Skin Temperature  : 
 Crepitus   : 
 Sub-cutaneous nodules : 
 Rheumatoid vasculitic lesion: 
 Lymphadenopathy  : 
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Enlargement: 
Soft Tissues   : 
 Bony Enlargement  : 
Range of Movements  : 
Examination of individual joints: 
 Cervical Spine  : 
 Thoracic Spine  : 
 Lumbar Spine  : 
 Sacro-illac Joint  : 
 Shoulder Joint  : 
 Elbow Joint   : 
 Wrist Joint   : 
 Metacarpophalangeal joint : 
 Interphalangeal Joint : 
 Hip Joint   : 
 Knee joint   : 
 Metatarso phalangeal Joint: 
Examination of individual joints (Affected Joints) Measurement (in cm) : 
Before and After Treatment: 
 RIGHT LEFT 
 BEFORE AFTER BEFORE AFTER 
Knee Joint 
Ankle Joint 
Wrist Joint 
Elbow joint 
Index finger 
Middle finger 
Ring finger 
Little finger 
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EXAMINATION OF OTHER SYSTEMS: 
1. Respiratory system  : 
2. Cardio Vascular system  : 
3. Gastro Intestinal system  : 
4. Central Nervous system  : 
5. Genito – Urinary Systam : 
 
DAILY PROGRESS 
 
DATE 
 
SYMPTOMS 
 
DRUG 
 
   
 
CLINICAL PARAMETERS AND PROGRESS 
S.No Clinical Feaures    Ist 
day 
5th 
day
10th 
day
15th 
day
20th 
day
25th 
day 
30th 
day 
40th 
day
1 Pain in Joints         
2 Early Morning Stiffness         
3 Tenderness & Swelling:  
Knee 
Ankle 
Wrist 
MCP 
PIP 
        
4 Depression         
5 Loss of appetite         
6 Fever         
7 Restriction of Joints 
Movements 
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8 Sub cutaneous nodules         
9 Deformity         
10 Muscle Weakness         
11 Muscle Wasting         
12 Ulnar Deviation         
13 Entrapment Neuropathy         
  
+++ - Severe 
++  - Moderate  
+  - Mild 
-  - Nil 
DIFFERENTIAL DIAGNOSIS 
1.  
2.  
3.  
FINAL DIAGNOSIS: 
LINE OF TREATMENT 
MEDICINE 
1 
2 
MEDICAL ADVICE 
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GOVERNMENT SIDDHA MEDIDCAL COLLEGE HOSPITAL, 
POST GRADUATE RESEARCH CENTRE, 
PALAYAMKOTTAI, TIRUNELVELI-627 002 
BRANCH – III SIRAPPU MARUTHUVAM. 
ADMISSION-DISCHARGE SHEET FOR “AZHALKEEL VAYU” 
 
IP No   :    Occupation : 
Bed No  :    Income : 
Ward   :    Nationality : 
Name   :    Religion : 
Age   :    Date of Admission : 
Sex   :    Date of Discharge : 
Permanent Address :    Diagnosis : 
       Result  : 
Temporary Address:   Medical officer : 
CLINICAL PICTURES 
Sl.No. During Admission During Discharge 
   
 
PLACE: 
DATE:      Signature of Medical Officer. 
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